The present invention relates to a modified microorganism, to a method for producing an organ- ic compound and to the use of a modified microorganism.

Organic compounds such as small dicarboxylic acids having 6 or fewer carbons are commercially significant chemicals with many uses. For example, the small diacids include 1 ,4-diacids, such as succinic acid, malic acid and tartaric acid, and the 5-carbon molecule itaconic acid. Other diacids include the two carbon oxalic acid, three carbon malonic acid, five carbon glutaric acid and the 6 carbon adipic acid and there are many derivatives of such diacids as well.

As a group the small diacids have some chemical similarity and their uses in polymer production can provide specialized properties to the resin. Such versatility enables them to fit into the downstream chemical infrastructure markets easily. For example, the 1 ,4-diacid molecules fulfill many of the uses of the large scale chemical maleic anhydride in that they are converted to a variety of industrial chemicals (tetrahydrofuran, butyrolactone, 1 ,4-butanediol, 2-pyrrolidone) and the succinate derivatives succindiamide, succinonitrile, diaminobutane and esters of succinate. Tartaric acid has a number of uses in the food, leather, metal and printing industries. Itaconic acid forms the starting material for production of 3-methylpyrrolidone, methyl-BDO, me- thyl-THF and others.

In particular, succinic acid or succinate - these terms are used interchangeably herein - has drawn considerable interest because it has been used as a precursor of many industrially im- portant chemicals in the food, chemical and pharmaceutical industries. In fact, a report from the U.S. Department of Energy reports that succinic acid is one of 12 top chemical building blocks manufactured from biomass. Thus, the ability to make diacids in bacteria would be of significant commercial importance. WO-A-2009/024294 discloses a succinic acid producing bacterial strain, being a member of the family of Pasteurellaceae, originally isolated from rumen, and capable of utilizing glycerol as a carbon source and variant and mutant strains derived there from retaining said capability, in particular, a bacterial strain designated DD1 as deposited with DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Inhoffenstr. 7B, D-38124 Braunschweig, Germany) having the deposit number DSM 18541 (ID 06-614) and having the ability to produce succinic acid. The DD1 -strain belongs to the species Basfia succiniciproducens and the family of Pasteurellaceae as classified by Kuhnert et a/., 2010. Mutations of these strains, in which the IdhA- gene and/or the pfID- or the pflA-gene have been disrupted, are disclosed in WO-A- 2010/092155, these mutant strains being characterized by a significantly increased production of succinic acid from carbon sources such as glycerol or mixtures of glycerol and carbohydrates such as maltose, under anaerobic conditions compared to the DD1 -wildtype disclosed in WO-A- 2009/024294. However, bio-based succinate still faces the challenge of becoming cost competitive against petrochemical-based alternatives. In order to develop the bio-based industrial production of succinic acid, it will be important to grow the cells in a low cost medium, and the working strain optimally should be able to metabolize a wide range of low-cost sugar feedstock to produce succinic acid in good yields so that the cheapest available raw materials can be used.

Sucrose (commonly known as sugar) is a disaccharide consisting of glucose and fructose, and it is a carbon source that is very abundant in nature and is produced from all plants having photosynthesis ability. Particularly, sugarcane and sugar beet contain large amounts of sucrose, and more than 60% of the world's sucrose is currently being produced from sugarcane. Particularly, sucrose is produced at a very low cost, because it can be industrially produced through a simple process of evaporating/concentrating extracts obtained by mechanical pressing of sug- arcanes. Sucrose as a raw material for producing chemical compounds through microbial fermentation is thus inexpensive and it also functions to protect the cell membrane from an exter- nal environment containing large amounts of desired metabolites, thus producing high- concentrations of desired metabolites as shown by Kilimann et al. (Biochimica et Biophysica Acta, 1764, 2006).

Even though sucrose is an excellent raw material having the above-described advantages, in- eluding low price and a function to protect microorganisms from an external environment, the disadvantage of this carbon source can be seen in the fact a large number of microorganisms do not have a complete mechanism of transporting sucrose into cell, degrading the transported sucrose and linking the degraded products to glycolysis, and thus cannot use sucrose as a carbon source. Even in the case of microorganisms having a mechanism capable of using sucrose, they cannot efficiently produce desired metabolites, because the rate of ingestion and degradation of sucrose as a carbon source is very low.

It was therefore an object of the present invention to overcome the disadvantages of the prior art.

In particular, it was an object of the present invention to provide microorganisms which can be used for the fermentative production of organic compounds such as succinic acid and that can efficiently utilize sucrose as the predominant carbon source without sacrificing growth rates or yields. Preferably said microorganisms would be able to use a number of low cost carbon sources and produce excellent yields of organic compounds such as succinic acid. Compared to the recombinant microorganisms of the prior art that are used for the fermentative production of succinic acid, the microorganisms of the present invention should be characterized by an increased succinic acid yield and an increased carbon yield during growth of the cells on sucrose as the predominant carbon source.

A contribution to achieving the abovementioned aims is provided by a modified microorganism having, compared to its wildtype, having, compared to its wildtype, a reduced activity of an enzyme encoded by the pfsA-gene,

a reduced activity of an enzyme encoded by the ptsH-gene or

a reduced activity of an enzyme encoded by the ptsA-gene and a reduced activity of an enzyme encoded by the ptsH-gene wherein the wildtype from which the modified microorganism has been derived belongs to the family of Pasteurellaceae.

A contribution to achieving the abovementioned aims is in particular provided by a modified mi- croorganism which the pfsA-gene or parts thereof,

the pfsH-gene or parts thereof, or

the pfsA-gene or parts thereof and the pfsH-gene or parts thereof have been deleted or in which a regulatory element of these genes or at least a part thereof has been deleted or in which at least one mutation has been introduced into these genes, wherein the wildtype from which the modified microorganism has been derived belongs to the family of Pasteurellaceae.

Surprisingly, it has been discovered that a reduction of the activity of the enzyme that is encoded by the pfsA-gene (this enzyme being the energy coupling Enzyme I of the phosphoenolpy- ruvate-dependent phosphotransferase system) and/or a reduction of the activity of the enzyme that is encoded by the pfsH-gene (this enzyme being the histidine-containing protein HPr of the phosphoenolpyruvate-dependent phosphotransferase system), for example by a deletion of the pfsA-gene or parts thereof and/or the pfsH-gene or parts thereof, in a microorganism that belongs to the family of Pasteurellaceae results in a modified microorganism that, compared to the corresponding microorganism in which the activity of this enzyme or these enzymes has not been decreased, is characterized by an increased yield of organic compounds such as succinic acid, especially if these modified microorganisms are grown on sucrose as the assimilable carbon source. This is indeed surprising as in microorganisms that belong to the family of Pasteurellaceae, such as those of the genus Basfia, in particular those of the species Basfia suc- ciniciproducens, the phosphoenolpyruvate-dependent phosphotransferase system (i. e. the PTS-system) is responsible of the uptake of fructose into the cells. When Sasf/a-strains are cul- tured on sucrose, the disaccharide is hydrolyzed inside the cell to obtain glucose-6-phosphat and fructose. Fructose, however, is secreted after hydrolysis and is taken up again by the cell using the fructose PTS-system. The person skilled in the art would therefore have assumed that an inactivation of the pfsA-gene and/or the pfsH-gene, which results in an inactivation of the PTS-system, would lead to a decreased formation of succinic acid when the cells are cultured on sucrose as the predominant carbon source as at least a part of the disaccharide (i. e. fructose) can not be imported into the cell. In context with the expression "a modified microorganism having, compared to its wildtype, a reduced activity of the enzyme that is encoded by the x-gene", wherein the x-gene is the ptsA- gene or the pfsH-gene and optionally, as described later, the IdhA-gene, the pflA-gene, the pflD- gene, the wcaJ-gene and/or the pykA-gene, the term "wildtype" refers to a microorganism in which the activity of the enzyme that is encoded by the x-gene has not been decreased, i. e. to a microorganism whose genome is present in a state as before the introduction of a genetic modification of the x-gene. Preferably, the expression " wildtype"ref ers to a microorganism (e.g., bacteria, yeast cell, fungal cell, etc.) whose genome, in particular whose x-gene, is present in a state as generated naturally as the result of evolution. The term is used both for the entire mi- croorganism and for individual genes. As a consequence, the term "wildtype" preferably does not cover in particular those microorganisms, or those genes, whose gene sequences have at least in part been modified by man by means of recombinant methods. The term "modified microorganism" thus includes a microorganism which has been genetically altered, modified or engineered (e.g., genetically engineered) such that it exhibits an altered, modified or different genotype and/or phenotype (e. g., when the genetic modification affects coding nucleic acid sequences of the microorganism) as compared to the naturally-occurring wildtype microorganism from which it was derived. According to a particular preferred embodiment of the modified microorganism according to the present invention the modified microorganism is a recombinant microorganism, which means that the microorganism has been obtained using recombinant DNA. The expression "recombinant DNA" as used herein refers to DNA sequences that result from the use of laboratory methods (molecular cloning) to bring together genetic material from multiple sources, creating sequences that would not otherwise be found in biological organisms. An example of such a recombinant DNA is a plasmid into which a heterologous DNA-sequence has been inserted.

The wildtype from which the microorganisms according to the present invention are derived belongs to the family of Pasteurellaceae. Pasteurellaceae comprise a large family of Gram- negative Proteobacteria with members ranging from bacteria such as Haemophilus influenzae to commensals of the animal and human mucosa. Most members live as commensals on mu- cosal surfaces of birds and mammals, especially in the upper respiratory tract. Pasteurellaceae are typically rod-shaped, and are a notable group of facultative anaerobes. They can be distinguished from the related Enterobacteriaceae by the presence of oxidase, and from most other similar bacteria by the absence of flagella. Bacteria in the family Pasteurellaceae have been classified into a number of genera based on metabolic properties and there sequences of the 16S RNA and 23S RNA. Many of the Pasteurellaceae contain pyruvate-formate-lyase genes and are capable of anaerobically fermenting carbon sources to organic acids.

According to a particular preferred embodiment of the modified microorganism according to the present invention the wildtype from which the modified microorganism has been derived be- longs to the genus Basfia and it is particularly preferred that the wildtype from which the modified microorganism has been derived belongs to the species Basfia succiniciproducens. Most preferably, the wildtype from which the modified microorganism according to the present invention as been derived is Basfia succiniciproducens-straln DD1 deposited under the Budapest Treaty with DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Inhoffenstr. 7B, D-38124 Braunschweig, Germany), Germany, having the deposit number DSM 18541 that has been deposited on August 1 1 , 2006. This strain has been originally isolated from the rumen of a cow of German origin. Pasteurella bacteria can be isolated from the gastrointestinal tract of animals and, preferably, mammals. The bacterial strain DD1 , in particular, can be isolated from bovine rumen and is capable of utilizing glycerol (including crude glycerol) as a carbon source. Further strains of the genus Basfia that can be used for preparing the modified microorganism according to the present invention are the Sasf/a-strain that is commercially available from the Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH under DSM number 22022 or the Sasf/a-strains that have been deposited with the Culture Collection of the University of Goteborg (CCUG, University of Gothenburg, Department of Clinical Bacteriology, Guldhedsgatan 10, SE-413 46 Goteborg), Sweden, having the deposit numbers

CCUG 57335, CCUG 57762, CCUG 57763, CCUG 57764, CCUG 57765 or CCUG 57766 on Februar 27, 2009. Said strains have been originally isolated from the rumen of cows of German or Swiss origin.

In this context it is particularly preferred that the wildtype from which the modified microorgan- ism according to the present invention has been derived has a 16S rDNA of SEQ ID NO: 1 or a sequence, which shows a sequence homology of at least 96 %, at least 97 %, at least 98 %, at least 99 % or at least 99.9% with SEQ ID NO: 1. It is also preferred that the wildtype from which the modified microorganism according to the present invention has been derived has a

23S rDNA of SEQ ID NO: 2 or a sequence, which shows a sequence homology of at least 96 %, at least 97 %, at least 98 %, at least 99 % or at least 99.9 % with SEQ ID NO: 2.

The identity in percentage values referred to in connection with the various polypeptides or polynucleotides to be used for the modified microorganism according to the present invention is, preferably, calculated as identity of the residues over the complete length of the aligned se- quences, such as, for example, the identity calculated (for rather similar sequences) with the aid of the program needle from the bioinformatics software package EMBOSS (Version 5.0.0, http://emboss.source-forge.net/what ) with the default parameters which are, i.e. gap open (penalty to open a gap): 10.0, gap extend (penalty to extend a gap): 0.5, and data file (scoring matrix file included in package): EDNAFUL.

It should be noted that the modified microorganism according to the present invention can not only be derived from the above mentioned wildtype-microorganisms, especially from Basfia succiniciproducens-straln DD1 , but also from variants of these strains. In this context the expression "a variant of a strain" comprises every strain having the same or essentially the same characteristics as the wildtype-strain. In this context it is particularly preferred that the

16 S rDNA of the variant has an identity of at least 90 %, preferably at least 95 %, more preferably at least 99 %, more preferably at least 99.5 %, more preferably at least 99.6 %, more pref- erably at least 99.7 %, more preferably at least 99.8 % and most preferably at least 99.9 % with the wildtype from which the variant has been derived. It is also particularly preferred that the 23 S rDNA of the variant has an identity of at least 90 %, preferably at least 95 %, more preferably at least 99 %, more preferably at least 99.5 %, more preferably at least 99.6 %, more pref- erably at least 99.7 %, more preferably at least 99.8 % and most preferably at least 99.9 % with the wildtype from which the variant has been derived. A variant of a strain in the sense of this definition can, for example, be obtained by treating the wildtype-strain with a mutagenizing chemical agent, X-rays, or UV light. The modified microorganism according to the present invention is characterized in that it has, compared to its wildtype, a reduced activity of an enzyme encoded by the pfsA-gene, a reduced activity of an enzyme encoded by the pfsH-gene or a reduced activity of an enzyme encoded by the pfsA-gene and a reduced activity of an enzyme encoded by the pfsH-gene. The reduction of the enzyme activity (A _ac tivit _y ) is defined as follows: activity of the modified microorganism _{1 nnn/}

χ 100% Ό

activity of the wildtype wherein, when determining A _ac tivit _y , the activity in the wildtype and the activity in the modified microorganism are determined under exactly the same conditions. Methods for the detection and determination of the activity of the enzyme that is encoded by the pfsA-gene and the ptsH- gene can be found, for example, in Reizer et al.: "Evidence for the presence of heat-stable protein (HPr) and ATP-dependent HPr kinase in heterofermentative lactobacilli lacking phosphoe- nolpyruvate:glycose phosphotransferase activity; Proc. Nadl. Acad. Sci. USA; Vol. 85, pages 2041 -2045 (1988).

The reduced activity of the enzymes disclosed herein, in particular the reduced activity of the enzyme encoded by the pfsA-gene and/or the pfsH-gene, the IdhA-gene, the pflA-gene, the pflD-gene and/or the wcaJ-gene, can be a reduction of the enzymatic activity by at least 50%, compared to the activity of said enzyme in the wildtype of the microorganism, or a reduction of the enzymatic activity by at least 90%, or more preferably a reduction of the enzymatic activity by at least 95%, or more preferably a reduction of the enzymatic activity by at least 98%, or even more preferably a reduction of the enzymatic activity by at least 99% or even more preferably a reduction of the enzymatic activity by at least 99.9%. In case of the pykA-gene the re- duced activity is preferably a reduction of the enzymatic activity by 0.1 to 99%, compared to the activity of said enzyme in the wildtype of the microorganism, or a reduction of the enzymatic activity by at least 15 %, or at least 25 %, or at least 35 %, or at least 45 %, or at least 55 %, or at least 65 %, or at least 75 % or at least 85 %, or at least 86 %, or at least 87 %, or at least 88 %, or at least 89 %, or at least 90 %, or at least 91 %, or at least 92 %, or at least 93 %, or at least 94 %,or at least 95 %, or at least 96 %, or at least 97 %, or at least 98 %, or at least 99 %. Preferably, the reduction of the activity of the enzyme encoded by the pykA-gene is in the range of 15 to 99 %, more preferably in the range of 50 to 95 % and even more preferably in the range of 90 to 99 %. The term "reduced activity of the enzyme that is encoded by the x-gene" also encompasses a modified microorganism which has no detectable activity of this particular enzyme.

The term "reduced activity of an enzyme" includes, for example, the expression of the enzyme by said genetically manipulated (e.g., genetically engineered) microorganism at a lower level than that expressed by the wildtype of said microorganism. Genetic manipulations for reducing the expression of an enzyme can include, but are not limited to, deleting the gene or parts thereof encoding for the enzyme, altering or modifying regulatory sequences or sites associated with expression of the gene encoding the enzyme (e.g., by removing strong promoters or repressive promoters), modifying proteins (e.g., regulatory proteins, suppressors, enhancers, transcriptional activators and the like) involved in transcription of the gene encoding the enzyme and/or the translation of the gene product, or any other conventional means of decreasing ex- pression of a particular gene routine in the art (including, but not limited to, the use of antisense nucleic acid molecules or other methods to knock-out or block expression of the target protein). Further on, one may introduce destabilizing elements into the mRNA or introduce genetic modifications leading to deterioration of ribosomal binding sites (RBS) of the RNA. It is also possible to change the codon usage of the gene in a way, that the translation efficiency and speed is decreased.

A reduced activity of an enzyme can also be obtained by introducing one or more gene mutations which lead to a reduced activity of the enzyme. Furthermore, a reduction of the activity of an enzyme may also include an inactivation (or the reduced expression) of activating enzymes which are necessary in order to activate the enzyme the activity of which is to be reduced. By the latter approach the enzyme the activity of which is to be reduced is preferably kept in an inactivated state.

Microorganisms having a reduced activity of the enzyme encoded by the ptsA-gene and/or the pfsH-gene may occur naturally, i.e. due to spontaneous mutations. A microorganism can be modified to lack or to have significantly reduced activity of the enzyme that is encoded by the ptsA-gene and/or the pfsH-gene by various techniques, such as chemical treatment or radiation. To this end, microorganisms will be treated by, e.g., a mutagenizing chemical agent, X-rays, or UV light. In a subsequent step, those microorganisms which have a reduced activity of the en- zyme that is encoded by the ptsA-gene and/or by the pfsH-gene will be selected. Modified microorganisms are also obtainable by homologous recombination techniques which aim to mutate, disrupt or excise the ptsA-gene and/or the pfsH-gene in the genome of the microorganism or to substitute the gene with a corresponding gene that encodes for an enzyme which, compared to the enzyme encoded by the wildtype-gene, has a reduced activity.

According to a preferred embodiment of the modified microorganism according to the present invention, a reduction of the activity of the enzyme encoded by the ptsA-gene and/or by the pfsH-gene is achieved by a modification of the ptsA-gene and the pfsH-gene, respectively, wherein this gene modification is preferably realized by a deletion of the ptsA-gene and/or the pfsH-gene or at least a part of these gene, a deletion of a regulatory element of the ptsA-gene and/or the pfsH-gene or parts of these regulatory elements, such as a promotor sequence, or by an introduction of at least one mutation into the ptsA-gene and/or into the pfsH-gene.

In the following, a suitable technique for recombination, in particular for introducing a mutation or for deleting sequences, is described. This technique is also sometimes referred to as the "Campbell recombination" herein (Leen- houts et al., Appl Env Microbiol. (1989), Vol. 55, pages 394-400). "Campbell in", as used herein, refers to a transformant of an original host cell in which an entire circular double stranded DNA molecule (for example a plasmid) has integrated into a chromosome by a single homologous recombination event (a cross in event), and that effectively results in the insertion of a linearized version of said circular DNA molecule into a first DNA sequence of the chromosome that is homologous to a first DNA sequence of the said circular DNA molecule. "Campbelled in" refers to the linearized DNA sequence that has been integrated into the chromosome of a "Campbell in" transformant. A "Campbell in" contains a duplication of the first homologous DNA sequence, each copy of which includes and surrounds a copy of the homologous recombination crossover point.

"Campbell out", as used herein, refers to a cell descending from a "Campbell in" transformant, in which a second homologous recombination event (a cross out event) has occurred between a second DNA sequence that is contained on the linearized inserted DNA of the "Campbelled in" DNA, and a second DNA sequence of chromosomal origin, which is homologous to the second DNA sequence of said linearized insert, the second recombination event resulting in the deletion (jettisoning) of a portion of the integrated DNA sequence, but, importantly, also resulting in a portion (this can be as little as a single base) of the integrated Campbelled in DNA remaining in the chromosome, such that compared to the original host cell, the "Campbell out" cell con- tains one or more intentional changes in the chromosome (for example, a single base substitution, multiple base substitutions, insertion of a heterologous gene or DNA sequence, insertion of an additional copy or copies of a homologous gene or a modified homologous gene, or insertion of a DNA sequence comprising more than one of these aforementioned examples listed above). A "Campbell out" cell is, preferably, obtained by a counter-selection against a gene that is con- tained in a portion (the portion that is desired to be jettisoned) of the "Campbelled in" DNA sequence, for example the Bacillus subtilis sacS-gene, which is lethal when expressed in a cell that is grown in the presence of about 5% to 10% sucrose. Either with or without a counter- selection, a desired "Campbell out" cell can be obtained or identified by screening for the desired cell, using any screenable phenotype, such as, but not limited to, colony morphology, col- ony color, presence or absence of antibiotic resistance, presence or absence of a given DNA sequence by polymerase chain reaction, presence or absence of an auxotrophy, presence or absence of an enzyme, colony nucleic acid hybridization, antibody screening, etc. The term "Campbell in" and "Campbell out" can also be used as verbs in various tenses to refer to the method or process described above.

It is understood that the homologous recombination events that leads to a "Campbell in" or "Campbell out" can occur over a range of DNA bases within the homologous DNA sequence, and since the homologous sequences will be identical to each other for at least part of this range, it is not usually possible to specify exactly where the crossover event occurred. In other words, it is not possible to specify precisely which sequence was originally from the inserted DNA, and which was originally from the chromosomal DNA. Moreover, the first homologous DNA sequence and the second homologous DNA sequence are usually separated by a region of partial non-homology, and it is this region of non-homology that remains deposited in a chromosome of the "Campbell out" cell.

Preferably, first and second homologous DNA sequence are at least about 200 base pairs in length, and can be up to several thousand base pairs in length. However, the procedure can be made to work with shorter or longer sequences. For example, a length for the first and second homologous sequences can range from about 500 to 2000 bases, and the obtaining of a "Campbell out" from a "Campbell in" is facilitated by arranging the first and second homologous sequences to be approximately the same length, preferably with a difference of less than 200 base pairs and most preferably with the shorter of the two being at least 70% of the length of the longer in base pairs.

The pfsA-gene the activity of which is reduced in the modified microorganism according to the present invention preferably comprises a nucleic acid selected from the group consisting of: a1 ) nucleic acids having the nucleotide sequence of SEQ ID NO: 3; nucleic acids encoding the amino acid sequence of SEQ ID NO: 4; c1 ) nucleic acids which are at least 70%, at least 80 %, at least 85 %, at least 90 %, at least 95 %, at least 96 %, at least 97 %, at least 98 %, at least 99 %, at least 99.5 %, at least 99.6 %, at least 99.7 %, at least 99.8 % or at least 99.9 %, most preferably 100 % identical to the nucleic acid of a1 ) or b1 ), the identity being the identity over the total length of the nucleic acids of a1 ) or b1 ); d1 ) nucleic acid encoding an amino acid sequence which is at least 70%, at least 80 %, at least 85 %, at least 90 %, at least 95 %, at least 96 %, at least 97 %, at least 98 %, at least 99 %, at least 99.5 %, at least 99.6 %, at least 99.7 %, at least 99.8 % or at least 99.9 %, most preferably 100 % identical to the amino acid sequence encoded by the nu- cleic acid of a1 ) or b1 ), the identity being the identity over the total length of amino acid sequence encoded by the nucleic acids of a1 ) or b1 ) nucleic acids capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to a1 ) or b1 ); and nucleic acids encoding the same protein as any of the nucleic acids of a1 ) or b1 ), but differing from the nucleic acids of a1 ) or b1 ) above due to the degeneracy of the genetic code.

The pfsH-gene the activity of which is reduced in the modified microorganism according to the present invention preferably comprises a nucleic acid selected from the group consisting of: a2) nucleic acids having the nucleotide sequence of SEQ ID NO: 5; nucleic acids encoding the amino acid sequence of SEQ ID NO: 6; c2) nucleic acids which are at least 70%, at least 80 %, at least 85 %, at least 90 %, at least 95 %, at least 96 %, at least 97 %, at least 98 %, at least 99 %, at least 99.5 %, at least 99.6 %, at least 99.7 %, at least 99.8 % or at least 99.9 %, most preferably 100 % identical to the nucleic acid of a2) or b2), the identity being the identity over the total length of the nucleic acids of a2) or b2); d2) nucleic acid encoding an amino acid sequence which is at least 70%, at least 80 %, at least 85 %, at least 90 %, at least 95 %, at least 96 %, at least 97 %, at least 98 %, at least 99 %, at least 99.5 %, at least 99.6 %, at least 99.7 %, at least 99.8 % or at least 99.9 %, most preferably 100 % identical to the amino acid sequence encoded by the nu- cleic acid of a2) or b2), the identity being the identity over the total length of amino acid sequence encoded by the nucleic acids of a2) or b2) e2) nucleic acids capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to a2) or b2); and f2) nucleic acids encoding the same protein as any of the nucleic acids of a2) or b2), but differing from the nucleic acids of a2) or b2) above due to the degeneracy of the genetic code. The term "hybridization" as used herein includes "any process by which a strand of nucleic acid molecule joins with a complementary strand through base pairing" (J. Coombs (1994) Dictionary of Biotechnology, Stockton Press, New York). Hybridization and the strength of hybridization (i.e., the strength of the association between the nucleic acid molecules) is impacted by such factors as the degree of complementarity between the nucleic acid molecules, stringency of the conditions involved, the Tm of the formed hybrid, and the G:C ratio within the nucleic acid molecules. As used herein, the term "Tm" is used in reference to the "melting temperature". The melting temperature is the temperature at which a population of double-stranded nucleic acid molecules becomes half dissociated into single strands. The equation for calculating the Tm of nucleic acid molecules is well known in the art. As indicated by standard references, a simple estimate of the Tm value may be calculated by the equation: Tm = 81.5 + 0.41 (% G+C), when a nucleic acid molecule is in aqueous solution at 1 M NaCI (see e.g., Anderson and Young, Quantitative Filter Hybridization, in Nucleic Acid Hybridization (1985)). Other references include more sophisticated computations, which take structural as well as sequence characteristics into account for the calculation of Tm. Stringent conditions, are known to those skilled in the art and can be found in Current Protocols in Molecular Biology, John Wiley & Sons, N.Y. (1989), 6.3.1 -6.3.6.

In particular, the term "stringency conditions" refers to conditions, wherein 100 contiguous nucleotides or more, 150 contiguous nucleotides or more, 200 contiguous nucleotides or more or 250 contiguous nucleotides or more which are a fragment or identical to the complementary nucleic acid molecule (DNA, RNA, ssDNA or ssRNA) hybridizes under conditions equivalent to hybridization in 7% sodium dodecyl sulfate (SDS), 0.5 M NaP04, 1 mM EDTA at 50°C with washing in 2 ^χ SSC, 0.1 % SDS at 50°C or 65°C, preferably at 65°C, with a specific nucleic acid molecule (DNA; RNA, ssDNA or ss RNA). Preferably, the hybridizing conditions are equivalent to hybridization in 7% sodium dodecyl sulfate (SDS), 0.5 M NaP04, 1 mM EDTA at 50°C with washing in 1 ^χ SSC, 0.1 % SDS at 50°C or 65°C, preferably 65°C, more preferably the hybridizing conditions are equivalent to hybridization in 7% sodium dodecyl sulfate (SDS), 0.5 M Na- P04, 1 mM EDTA at 50°C with washing in 0.1 * SSC, 0.1 % SDS at 50°C or 65°C, preferably 65°C. Preferably, the complementary nucleotides hybridize with a fragment or the whole wcaJ nucleic acids. Alternatively, preferred hybridization conditions encompass hybridisation at 65°C in 1 x SSC or at 42°C in 1 ^χ SSC and 50% formamide, followed by washing at 65°C in

0.3 x SSC or hybridisation at 50°C in 4 ^χ SSC or at 40°C in 6 x SSC and 50% formamide, followed by washing at 50°C in 2 ^χ SSC. Further preferred hybridization conditions are 0.1 % SDS, 0.1 SSD and 65°C. The pfsA-gene and/or the pfsH-gene or parts of these genes that may be deleted by the above mentioned "Campbell recombination" or in which at least one mutation is introduced by the above mentioned "Campbell recombination" preferably comprises a nucleic acid as defined above. Nucleic acid having the nucleotide sequence of SEQ ID NO: 3 and SEQ ID NO: 5 correspond to the pfsA-gene and the pfsH-gene of Basfia succiniciproducens-stra ^' m DD1 .

According to a preferred embodiment of the modified microorganism according to the present invention, this microorganism is not only characterized by a reduced activity of the enzyme en- coded by the pfsA-gene and/or the pfsH-gene, but also, compared to the wildtype, by at least one of the following properties: i) a reduced pyruvate formate lyase activity; ii) a reduced lactate dehydrogenase activity; iii) a reduced activity of an enzyme encoded by the wcaJ-gene; iv) a reduced activity of an enzyme encoded by the pykA-gene.

In this context particularly preferred modified microorganism are those having the following properties or combination of properties: i), ii), iii), iv), i)ii), i)iii), i)iv), ii)iii), ii)iv), iii)iv), i)ii)iii), i)ii)iv), i)iii)iv), ii)iii)iv) and i)ii)iii)iv), wherein a modified microorganism that is characterized by properties i), ii), iii) and iv) is most preferred.

Modified microorganisms being deficient in lactate dehydrogenase and/or being deficient in py- ruvate formate lyase activity are disclosed in WO-A-2010/092155, US 2010/0159543 and WO- A-2005/052135, the disclosure of which with respect to the different approaches of reducing the activity of lactate dehydrogenase and/or pyruvate formate lyase in a microorganism, preferably in a bacterial cell of the genus Pasteurella, particular preferred in Basfia succiniciproducens strain DD1 , is incorporated herein by reference. Methods for determining the pyruvate formate lyase activity are, for example, disclosed by Asanuma N. and Hino T. in "Effects ofpH and Energy Supply on Activity and Amount of Pyruvate-Formate-Lyase in Streptococcus bovis", Appl. Environ. Microbiol. (2000), Vol. 66, pages 3773-3777 and methods for determining the lactate dehydrogenase activity are, for example, disclosed by Bergmeyer, H.U., Bergmeyer J. and Grassl, M. (1983-1986) in "Methods of Enzymatic Analysis", 3 ^rd Edition, Volume III, pages 126- 133, Verlag Chemie, Weinheim.

In this context it is preferred that the reduction of the activity of lactate dehydrogenase is achieved by an inactivation of the IdhA-gene (which encodes the lactate dehydrogenase; LdhA; EC 1 .1 .1.27 or EC 1 .1 .1 .28) and the reduction of the pyruvate formate lyase is achieved by an inactivation of the pflA-gene (which encodes for an activator of pyruvate formate lyase; PfIA; EC 1 .97.1 .4) or the pflD-gene (which encodes the pyruvate formate lyase; PfID; EC 2.3.1.54), wherein the inactivation of these genes (i. e. IdhA, pfIA and pfID) is preferably achieved by a deletion of theses genes or parts thereof, by a deletion of a regulatory element of these genes or at least a part thereof of by an introduction of at least one mutation into these genes, particu- lar preferred by means of the "Campbell recombination" as described above.

A reduction of the activity of the enzyme encoded by the wcaJ-gene is preferably achieved by a modification of the wcaJ-gene, wherein this gene modification is preferably realized by a deletion of the wcaJ-gene or at least a part thereof, a deletion of a regulatory element of the wcaJ- gene or at least a part thereof, such as a promotor sequence, or by an introduction of at least one mutation into the wcaJ-gene. In context with the introduction of at least one mutation into the wcaJ-gene it is particularly preferred that the at least one mutation leads to the expression of a truncated enzyme encoded by the wcaJ-gene. It is furthermore preferred that in the truncated enzyme at least 100 amino acids, preferably at least 125 amino acids, more preferred at least 150 amino acids and most preferred at least 160 amino acids of the wildtype enzyme encoded by the wcaJ-gene are deleted from the C-terminal end. Such a truncated enzyme encod- ed the wcaJ-gene can, for example, be obtained by inserting or deleting nucleotides at appropriate positions within the wcaJ-gene which leads to a frame shift mutation, wherein by means of this frame shift mutation a stop codon introduced. For example, insertion of a nucleotide in the codon that encodes of lysine between thymine at position 81 and adenine at position 82 leads to a frame shift mutation by means of which a stop codon is introduced as shown in SEQ ID NO: 13. Such mutations of the wcaJ-gene can be introduced, for example, by site-directed or random mutagenesis, followed by an introduction of the modified gene into the genome of the microorganism by recombination. Variants of the wcaJ -gene can be are generated by mutating the wcaJ-gene sequence SEQ ID NO: 13 by means of PCR. The "Quickchange Site-directed Mutagenesis Kit' (Stratagene) can be used to carry out a directed mutagenesis. A random mu- tagenesis over the entire coding sequence, or else only part thereof, of SEQ ID NO: 13 can be performed with the aid of the "GeneMorph II Random Mutagenesis Kit' (Stratagene).

A reduction of the activity of the enzyme encoded by the pykA-gene is preferably achieved by introducing at least one mutation into the pykA-gene, preferably into the wildtype-py/oA-gene. In this context it is particularly preferred that the at least one mutation leads to a modification of the nucleic acid sequence of the pykA-gene, such that the amino acid sequence of the enzyme encoded by the modified gene differs from the amino acid sequence of the enzyme encoded by the wildtype pykA-gene in at least one amino acid. A mutation into the pykA-gene can be introduced, for example, by site-directed or random mutagenesis, followed by an introduction of the modified gene into the genome of the microorganism by recombination. Variants of the pykA- gene can be are generated by mutating the gene sequence SEQ ID NO: 15 by means of PCR. The "Quickchange Site-directed Mutagenesis Kit' (Stratagene) can be used to carry out a directed mutagenesis. A random mutagenesis over the entire coding sequence, or else only part thereof, of SEQ ID NO: 15 can be performed with the aid of the "GeneMorph II Random Muta- genesis Kit' (Stratagene). The mutagenesis rate is set to the desired amount of mutations via the amount of the template DNA used. Multiple mutations are generated by the targeted combination of individual mutations or by the sequential performance of several mutagenesis cycles.

The IdhA-gene the activity of which may be reduced in the modified microorganism according to the present invention preferably comprises a nucleic acid selected from the group consisting of: a1 ) nucleic acids having the nucleotide sequence of SEQ ID NO: 7; a2) nucleic acids encoding the amino acid sequence of SEQ ID NO: 8; a3) nucleic acids which are at least 70 %, at least 80 %, at least 85 %, at least 90 %, at least 95 %, at least 96 %, at least 97 %, at least 98 %, at least 99 %, at least 99.5 %, at least 99.6 %, at least 99.7 %, at least 99.8 % or at least 99.9 %, most preferably 100 % identical to the nucleic acid of a1 ) or a2), the identity being the identity over the total length of the nucleic acids of a1 ) or a2); a4) nucleic acids encoding an amino acid sequence which is at least 70 %, at least 80 %, at least 85 %, at least 90 %, at least 95 %, at least 96 %, at least 97 %, at least 98 %, at least 99 %, at least 99.5 %, at least 99.6 %, at least 99.7 %, at least 99.8 % or at least 99.9 %, most preferably 100 % identical to the amino acid sequence encoded by the nucleic acid of a1 ) or a2), the identity being the identity over the total length of amino acid sequence encoded by the nucleic acids of a1 ) or a2); a5) nucleic acids capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to a1 ) or a2); and a6) nucleic acids encoding the same protein as any of the nucleic acids of a1 ) or a2), but differing from the nucleic acids of a1 ) or a2) above due to the degeneracy of the genetic code.

Nucleic acid having the nucleotide sequence of SEQ ID NO: 7 correspond to the Idh-gene of Basfia succiniciproducens-stra ^' m DDL

The pflA-gene the activity of which may be reduced in the modified microorganism according to the present invention preferably comprises a nucleic acid selected from the group consisting of: β1 ) nucleic acids having the nucleotide sequence of SEQ ID NO: 9; β2) nucleic acids encoding the amino acid sequence of SEQ ID NO: 10; β3) nucleic acids which are at least 70 %, at least 80 %, at least 85 %, at least 90 %, at least 95 %, at least 96 %, at least 97 %, at least 98 %, at least 99 %, at least 99.5 %, at least

99.6 %, at least 99.7 %, at least 99.8 % or at least 99.9 %, most preferably 100 % identical to the nucleic acid of β1 ) or β2), the identity being the identity over the total length of the nucleic acids of β1 ) or β2); β4) nucleic acids encoding an amino acid sequence which is at least 70 %, at least 80 %, at least 85 %, at least 90 %, at least 95 %, at least 96 %, at least 97 %, at least 98 %, at least 99 %, at least 99.5 %, at least 99.6 %, at least 99.7 %, at least 99.8 % or at least 99.9 %, most preferably 100 % identical to the amino acid sequence encoded by the nucleic acid of β1 ) or β2), the identity being the identity over the total length of amino acid sequence encoded by the nucleic acids of β1 ) or β2); β5) nucleic acids capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to β1 ) or β2); and β6) nucleic acids encoding the same protein as any of the nucleic acids of β1 ) or β2), but dif- fering from the nucleic acids of β1 ) or β2) above due to the degeneracy of the genetic code.

Nucleic acid having the nucleotide sequence of SEQ ID NO: 9 correspond to the pflA-gene of Basfia succiniciproducens-stra ^' m DDL

The pflD-gene the activity of which may be reduced in the modified microorganism according to the present invention preferably comprises a nucleic acid selected from the group consisting of: γ1 ) nucleic acids having the nucleotide sequence of SEQ ID NO: 11 ; γ2) nucleic acids encoding the amino acid sequence of SEQ ID NO: 12; γ3) nucleic acids which are at least 70 %, at least 80 %, at least 85 %, at least 90 %, at least 95 %, at least 96 %, at least 97 %, at least 98 %, at least 99 %, at least 99.5 %, at least 99.6 %, at least 99.7 %, at least 99.8 % or at least 99.9 %, most preferably 100 % identical to the nucleic acid of γ1 ) or y2), the identity being the identity over the total length of the nucleic acids of γ1 ) or y2); γ4) nucleic acids encoding an amino acid sequence which is at least 70 %, at least 80 %, at least 85 %, at least 90 %, at least 95 %, at least 96 %, at least 97 %, at least 98 %, at least 99 %, at least 99.5 %, at least 99.6 %, at least 99.7 %, at least 99.8 % or at least 99.9 %, most preferably 100 % identical to the amino acid sequence encoded by the nucleic acid of γ1 ) or y2), the identity being the identity over the total length of amino acid sequence encoded by the nucleic acids of γ1 ) or y2); γ5) nucleic acids capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to γ1 ) or γ2); and γ6) nucleic acids encoding the same protein as any of the nucleic acids of γ1 ) or y2), but dif- fering from the nucleic acids of γ1 ) or γ2) above due to the degeneracy of the genetic code.

Nucleic acid having the nucleotide sequence of SEQ ID NO: 11 correspond to the pflD-gene of Basfia succiniciproducens-stra ^' m DDL The wcaJ-ge e the activity of which may be reduced in the modified microorganism according to the present invention preferably comprises a nucleic acid selected from the group consisting of: δ1 ) nucleic acids having the nucleotide sequence of SEQ ID NO: 13; δ2) nucleic acids encoding the amino acid sequence of SEQ ID NO: 14; δ3) nucleic acids which are at least 70 %, at least 80 %, at least 85 %, at least 90 %, at least 95 %, at least 96 %, at least 97 %, at least 98 %, at least 99 %, at least 99.5 %, at least

99.6 %, at least 99.7 %, at least 99.8 % or at least 99.9 %, most preferably 100 % identical to the nucleic acid of δ1 ) or δ2), the identity being the identity over the total length of the nucleic acids of δ1 ) or δ2); δ4) nucleic acids encoding an amino acid sequence which is at least 70 %, at least 80 %, at least 85 %, at least 90 %, at least 95 %, at least 96 %, at least 97 %, at least 98 %, at least 99 %, at least 99.5 %, at least 99.6 %, at least 99.7 %, at least 99.8 % or at least 99.9 %, most preferably 100 % identical to the amino acid sequence encoded by the nucleic acid of δ1 ) or δ2), the identity being the identity over the total length of amino acid sequence encoded by the nucleic acids of δ1 ) or δ2); δ5) nucleic acids capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to δ1 ) or δ2); and δ6) nucleic acids encoding the same protein as any of the nucleic acids of δ1 ) or δ2), but differing from the nucleic acids of δ1 ) or δ2) above due to the degeneracy of the genetic code.

Nucleic acid having the nucleotide sequence of SEQ ID NO: 13 correspond to the wcaJ-gene of Basfia succiniciproducens-stra ^' m DD1 .

The pykA-gene the activity of which may be reduced in the modified microorganism according to the present invention preferably comprises a nucleic acid selected from the group consisting of: ε1 ) nucleic acids having the nucleotide sequence of SEQ ID NO: 15; s2) nucleic acids encoding the amino acid sequence of SEQ ID NO: 16; s3) nucleic acids which are at least 70 %, at least 80 %, at least 85 %, at least 90 %, at least 95 %, at least 96 %, at least 97 %, at least 98 %, at least 99 %, at least 99.5 %, at least 99.6 %, at least 99.7 %, at least 99.8 % or at least 99.9 %, most preferably 100 % identi- cal to the nucleic acid of ε1 ) or ε2), the identity being the identity over the total length of the nucleic acids of ε1 ) or s2); s4) nucleic acids encoding an amino acid sequence which is at least 70 %, at least 80 %, at least 85 %, at least 90 %, at least 95 %, at least 96 %, at least 97 %, at least 98 %, at least 99 %, at least 99.5 %, at least 99.6 %, at least 99.7 %, at least 99.8 % or at least 99.9 %, most preferably 100 % identical to the amino acid sequence encoded by the nucleic acid of ε1 ) or ε2), the identity being the identity over the total length of amino acid sequence encoded by the nucleic acids of ε1 ) or s2); s5) nucleic acids capable of hybridizing under stringent conditions with a complementary sequence of any of the nucleic acids according to ε1 ) or s2); and s6) nucleic acids encoding the same protein as any of the nucleic acids of ε1 ) or ε2), but differing from the nucleic acids of ε1 ) or ε2) above due to the degeneracy of the genetic code.

Nucleic acid having the nucleotide sequence of SEQ ID NO: 15 correspond to the pykA-gene of Basfia succiniciproducens-stra ^' m DDL

In this context it is preferred that the modified microorganism according to the present invention comprises at least one of the following genetic modifications A) to E):

A) a deletion of the IdhA-gene or at least a part thereof, a deletion of a regulatory element of the IdhA-gene or at least a part thereof or an introduction of at least one mutation into the IdhA-gene;

B) a deletion of the pflD-gene or at least a part thereof, a deletion of a regulatory element of the pflD-gene or at least a part thereof or an introduction of at least one mutation into the pflD-gene; or a deletion of the pflA-gene or at least a part thereof, a deletion of a regulatory element of the pflA-gene or at least a part thereof or an introduction of at least one mutation into the pflA-gene;

C) a deletion of the wcaJ-gene or at least a part thereof, a deletion of a regulatory element of the wcaJ-gene or at least a part thereof or an introduction of at least one mutation into the wcaJ-gene; D) a deletion of the pykA -gene or at least a part thereof, a deletion of a regulatory element of the pykA-gene or at least a part thereof or an introduction of at least one mutation into the pykA-gene that least to a reduction of the activity of the enzyme encodes by the pykA- gene;

E) a deletion of the pfsA-gene or at least a part thereof, a deletion of a regulatory element of the pfsA-gene or at least a part thereof or an introduction of at least one mutation into the ptsA-gene and/or a deletion of the pfsH-gene or at least a part thereof, a deletion of a regulatory element of the pfsH-gene or at least a part thereof or an introduction of at least one mutation into the pfsH-gene.

In this context particularly preferred modified microorganism are those having the following properties or combination of properties: A), B), C), D), E), A)B), A)C), A)D) A)E), B)C), B)D), B)E), C)D), C)E), D)E), A)B)C), A)B)D), A)B)E), A)C)D), A)C)E), A)D)E), B)C)D), B)C)E), B)D)E)m C)D)E), A)B)C)D), A)B)C)E),A)B)D)E), A)C)D)E, B)C)D)E) and A)B)C)D)E), wherein a modified microorganism that is characterized by properties A), B), C), D) and E) is most preferred.

According to a first particularly preferred embodiment of the modified microorganism according to the present invention the microorganism comprises the following genetic modifications A) to E):

A) a deletion of the IdhA-gene or at least a part thereof;

B) a deletion of the pflA-gene or at least a part thereof or a deletion of the pflD-gene or at least a part thereof;

C) an introduction of at least one mutation into the wcaJ-gene that lead to the expression of a truncated enzyme encoded by the wcaJ-gene; D) an introduction of at least one mutation into the pykA-gene that least to a reduction of the activity of the enzyme encodes by the pykA-gene; and

E) a deletion of the pfsA-gene or at least a part thereof. According to a second particularly preferred embodiment of the modified microorganism according to the present invention the microorganism comprises the following genetic modifications A) to E): A) a deletion of the IdhA-gene or at least a part thereof;

B) a deletion of the pflA-gene or at least a part thereof or a deletion of the pflD-gene or at least a part thereof;

C) an introduction of at least one mutation into the wcaJ-gene that lead to the expression of a truncated enzyme encoded by the wcaJ-gene; D) an introduction of at least one mutation into the pykA-gene that least to a reduction of the activity of the enzyme encodes by the pykA-gene; and

E) a deletion of the ptsH-gene or at least a part thereof. Particular preferred embodiments of the modified microorganisms according to the present invention are: modified bacterial cells of the family Pasteurellaceae, in particular preferred of the genus Basfia and even more preferred of the species Basfia succiniciproducens, in which the activity of the enzyme encoded by the pfsA-gene has been reduced, preferably by a deletion of the pfsA-gene, in particular by a modification of the ptsA- gene having the nucleic acid sequence according to SEQ ID NO: 3 and encoding for an enzyme having the amino acid sequence according to SEQ ID NO: 4; in which the activity of the lactate dehydrogenase and the pyruvate formate lyase are reduced, preferably by a modification of the IdhA-gene and the pflA-gene, in particular by a modification of the IdhA-gene having the nucleic acid sequence according to SEQ ID NO: 7 and encoding for LdhA having the amino acid sequence according to SEQ ID NO: 8 and by a modification of the pflA-gene having the nucleic acid sequence according to SEQ ID NO: 9 and encoding for PfIA having the amino acid sequence according to SEQ ID NO: 10, or a modification of the IdhA-gene and the pflD-gene, in particular by a modification of the IdhA-gene having the nucleic acid sequence according to SEQ ID NO: 7 and encoding for LdhA having the amino acid sequence according to SEQ ID NO: 8 and by a modification of the pflD-gene having the nucleic acid sequence according to SEQ ID NO: 11 and encoding for PAD having the amino acid sequence according to SEQ ID NO: 12; in which the wcaJ-gene or at least a part thereof has been deleted or wherein at least one mutation has been introduced in the wcaJ-gene, in particular in the wcaJ- gene having the nucleic acid sequence according to SEQ ID NO: 13 and encoding for a protein having the amino acid sequence according to SEQ ID NO: 14, wherein the introduction of the at least one mutation preferably leads expression of an enzyme in which at least 100 amino acids, preferably at least 125 amino acids, more preferred at least 150 amino acids and most preferred at least 160 amino acids of the wildtype enzyme encoded by the wcaJ-gene are deleted from the C-terminal end; and in which at least one mutation has been introduced in the pykA-gene, in particular in the pykA-gene having the nucleic acid sequence according to SEQ ID NO: 15 and encoding for a protein having the amino acid sequence according to

SEQ ID NO: 16, preferably at least one mutation the results in the substitution of at least one amino acid in the enzyme encoded by the pykA-gene, most preferred a mutation that results at least in a substitution of glycine by cysteine a position 167, or a substitution of cysteine by tyrosine at position 417 or a substitution of alanine by glycine at position 171 , or a substitution glycine by cysteine a position 167 and a substitution of cysteine by tyrosine at position 417, or a substitution of glycine by cysteine a position 167 and a substitution of alanine by glycine at position 171 , or a substitution of cysteine by tyrosine at position 417 and a substitution of alanine by glycine at position 171 , or a substitution glycine by cysteine a position 167, a substitution of cysteine by tyrosine at position 417 and a substitution of alanine by glycine at position 171 in the enzyme encoded by the pykA-gene. modified bacterial cells of the family Pasteurellaceae, in particular preferred of the genus Basfia and even more preferred of the species Basfia succiniciproducens, in which the activity of the enzyme encoded by the pfsH-gene has been reduced, preferably by a deletion of the pfsH-gene, in particular by a modification of the ptsH- gene having the nucleic acid sequence according to SEQ ID NO: 5 and encoding for an enzyme having the amino acid sequence according to SEQ ID NO: 6; in which the activity of the lactate dehydrogenase and the pyruvate formate lyase are reduced, preferably by a modification of the IdhA-gene and the pflA-gene, in particular by a modification of the IdhA-gene having the nucleic acid sequence according to SEQ ID NO: 7 and encoding for LdhA having the amino acid sequence according to SEQ ID NO: 8 and by a modification of the pflA-gene having the nucleic acid sequence according to SEQ ID NO: 9 and encoding for PfIA having the amino acid sequence according to SEQ ID NO: 10, or a modification of the IdhA-gene and the pflD-gene, in particular by a modification of the IdhA-gene having the nucleic acid sequence according to SEQ ID NO: 7 and encoding for LdhA having the amino acid sequence according to SEQ ID NO: 8 and by a modification of the pflD-gene having the nucleic acid sequence according to SEQ ID NO: 11 and encoding for PAD having the amino acid sequence according to SEQ ID NO: 12; in which the wcaJ-ge e or at least a part thereof has been deleted or wherein at least one mutation has been introduced in the wcaJ-gene, in particular in the wcaJ- gene having the nucleic acid sequence according to SEQ ID NO: 13 and encoding for a protein having the amino acid sequence according to SEQ ID NO: 14, wherein the introduction of the at least one mutation preferably leads expression of an enzyme in which at least 100 amino acids, preferably at least 125 amino acids, more preferred at least 150 amino acids and most preferred at least 160 amino acids of the wildtype enzyme encoded by the wcaJ-gene are deleted from the C-terminal end; and in which at least one mutation has been introduced in the pykA-gene, in particular in the pykA-gene having the nucleic acid sequence according to SEQ ID NO: 15 and encoding for a protein having the amino acid sequence according to

SEQ ID NO: 16, preferably at least one mutation the results in the substitution of at least one amino acid in the enzyme encoded by the pykA-gene, most preferred a mutation that results at least in a substitution of glycine by cysteine a position 167, or a substitution of cysteine by tyrosine at position 417 or a substitution of alanine by glycine at position 171 , or a substitution glycine by cysteine a position 167 and a substitution of cysteine by tyrosine at position 417, or a substitution of glycine by cysteine a position 167 and a substitution of alanine by glycine at position 171 , or a substitution of cysteine by tyrosine at position 417 and a substitution of alanine by glycine at position 171 , or a substitution glycine by cysteine a position 167, a substitution of cysteine by tyrosine at position 417 and a substitution of alanine by glycine at position 171 in the enzyme encoded by the pykA-gene.

A contribution to solving the problems mentioned at the outset is furthermore provided by a method of producing an organic compound comprising:

I) cultivating the modified microorganism according to the present invention in a culture me- dium comprising at least one assimilable carbon source to allow the modified microorganism to produce the organic compound, thereby obtaining a fermentation broth comprising the organic compound;

II) recovering the organic compound from the fermentation broth obtained in process step I).

In process step I) the modified microorganism according to the present invention is cultured in a culture medium comprising at least one assimilable carbon source to allow the modified micro- organism to produce the organic compound, thereby obtaining a fermentation broth comprising the organic compound. Preferred organic compounds that can be produced by the process according to the present invention comprise carboxylic acids such as formic acid, lactic acid, propionic acid, 2-hydroxypropionic acid, 3-hydroxypropionic acid, 3-hydroxybutyric acid, acrylic acid, pyruvic acid or salts of these carboxylic acids, dicarboxylic acids such as malonic acid, succinic acid, malic acid, tartaric acid, glutaric acid, itaconic acid, adipic acid or salts thereof, tricarboxylic acids such as citric acid or salts thereof, alcohols such as methanol or ethanol, amino acids such as L-asparagine, L-aspartic acid, L-arginine, L-isoleucine, L-glycine, L- glutamine, L-glutamic acid, L-cysteine, L-serine, L-tyrosine, L-tryptophan, L-threonine, L-valine, L-histidine, L-proline, L-methionine, L-lysine, L-leucine, etc..

According to a preferred embodiment of the process according to the present invention the organic compound is succinic acid. The term "succinic acid', as used in the context of the present invention, has to be understood in its broadest sense and also encompasses salts thereof (i. e. succinate), as for example alkali metal salts, like Na ⁺ and K ⁺ -salts, or earth alkali salts, like Mg ²⁺ and Ca ²⁺ -salts, or ammonium salts or anhydrides of succinic acid.

The modified microorganism according to the present invention is, preferably, incubated in the culture medium at a temperature in the range of about 10 to 60°C or 20 to 50°C or 30 to 45°C at a pH of 5.0 to 9.0 or 5.5 to 8.0 or 6.0 to 7.0.

Preferably, the organic compound, especially succinic acid, is produced under anaerobic conditions. Anaerobic conditions may be established by means of conventional techniques, as for example by degassing the constituents of the reaction medium and maintaining anaerobic con- ditions by introducing carbon dioxide or nitrogen or mixtures thereof and optionally hydrogen at a flow rate of, for example, 0.1 to 1 or 0.2 to 0.5 vvm. Aerobic conditions may be established by means of conventional techniques, as for example by introducing air or oxygen at a flow rate of, for example, 0.1 to 1 or 0.2 to 0.5 vvm. If appropriate, a slight over pressure of 0.1 to 1.5 bar may be applied in the process.

The assimilable carbon source is preferably selected from sucrose, maltose, maltotriose, malto- tetraose, maltopentaose, maltohexaose, maltoheptaose, D-fructose, D-glucose, D-xylose, L- arabinose, D-galactose, D-mannose, glycerol and mixtures thereof or compositions containing at least one of said compounds, or is selected from decomposition products of starch, cellulose, hemicellulose and/or lignocellulose. A preferred assimilable carbon source is sucrose. Further preferred mixtures are a mixture of sucrose and at least one further assimilable carbon source, such as a mixture of sucrose and maltose, sucrose and D-fructose, sucrose and D-glucose, sucrose and D-xylose, sucrose and L-arabinose, sucrose and D-galactose, sucrose and D- mannose.

According to a preferred embodiment of the process according to the present invention at least 50 wt.-%, preferably at least 75 wt.-%, more preferably at least 90 wt.-%, even more preferably at least 95 wt.-% and most preferably at least 99 wt.-% of the assimilable carbon source, based on the total weight of the assimilable carbon source with the exception of carbon dioxide, is sucrose. The initial concentration of the assimilable carbon source, preferably the initial concentration of sucrose, is preferably adjusted to a value in a range of 5 to 100 g/l, preferably 5 to 75 g/l and more preferably 5 to 50 g/l and may be maintained in said range during cultivation. The pH of the reaction medium may be controlled by addition of suitable bases as for example, gaseous ammonia, NH4HCO3, (NH ₄ ) ₂ C0 ₃ , NaOH, Na ₂ C0 ₃ , NaHC0 ₃ , KOH, K ₂ C0 ₃ , KHC0 ₃ , Mg(OH) ₂ , MgC0 ₃ , Mg(HC0 ₃ ) ₂ , Ca(OH) ₂ , CaC0 ₃ , Ca(HC0 ₃ ) ₂ , CaO, CH ₆ N ₂ 0 ₂ , C ₂ H ₇ N and/or mixtures thereof. These alkaline neutralization agents are especially required if the organic compounds that are formed in the course of the fermentation process are carboxylic acids or dicarboxylic acids. In the case of succinic acid as the organic compound, Mg(OH) ₂ is a particular preferred base.

The fermentation step I) according to the present invention can, for example, be performed in stirred fermenters, bubble columns and loop reactors. A comprehensive overview of the possible method types including stirrer types and geometric designs can be found in Chmiel: "Bio- prozesstechnik: Einfuhrung in die Bioverfahrenstechnik' , Volume 1. In the process according to the present invention, typical variants available are the following variants known to those skilled in the art or explained, for example, in Chmiel, Hammes and Bailey: "Biochemical Engineering", such as batch, fed-batch, repeated fed-batch or else continuous fermentation with and without recycling of the biomass. Depending on the production strain, sparging with air, oxygen, carbon dioxide, hydrogen, nitrogen or appropriate gas mixtures may be effected in order to achieve good yield (YP/S).

Particularly preferred conditions for producing the organic acid, especially succinic acid, in process step I) are: Assimilable carbon source: sucrose

Temperature: 30 to 45°C

pH: 5.5 to 7.0

Supplied gas: C0 ₂ It is furthermore preferred in process step I) that the assimilable carbon source, preferably sucrose, is converted to the organic compound, preferably to succinic acid, with a carbon yield YP/S of at least 0.5 g/g up to about 1 .18 g/g; as for example a carbon yield YP/S of at least 0,6 g/g, of at least 0.7 g/g, of at least 0.75 g/g, of at least 0.8 g/g, of at least 0.85 g/g, of at least 0.9 g/g, of at least 0.95 g/g, of at least 1.0 g/g, of at least 1 .05 g/g or of at least 1.1 g/g (organic compound/carbon, preferably succinic acid/carbon). It is furthermore preferred in process step I) that the assimilable carbon source, preferably sucrose, is converted to the organic compound, preferably to succinic acid, with a specific productivity yield of at least 0.6 g g DCW- ¹ h- ¹ organic compound, preferably succinic acid, or of at least of at least 0.65 g g DCW- ¹ lr ¹ , of at least 0.7 g g DCW- ¹ h- ¹ , of at least 0.75 g g DCW- ¹ h ^"1 or of at least 0.77 g g DCW- ¹ lr ¹ organic compound, preferably succinic acid.

It is furthermore preferred in process step I) that the assimilable carbon source, preferably sucrose, is converted to the organic compound, preferably to succinic acid, with a space time yield for the organic compound, preferably for succinic acid, of at least 2.2 g/(l_xh) or of at least 2.5 g/(Lxh) , at least 2.75 g/(Lxh), at least 3 g/(Lxh), at least 3.25 g/(Lxh), at least 3.5 g/(Lxh), at least 3.7 g/(l_xh), at least 4.0 g/(l_xh) at least 4.5 g/(l_xh) or at least 5.0 g/(l_xh) of the organic compound, preferably succinic acid. According to another preferred embodiment of the process according to the present invention in process step I) the modified microorganism is converting at least 20 g/L, more preferably at least 25 g/l and even more preferably at least 30 g/l of the as- similable carbon source, preferably sucrose, to at least 20 g/l, more preferably to at least 25 g/l and even more preferably at least 30 g/l of the organic compound, preferably succinic acid.

The different yield parameters as described herein (^'carbon yield' or "YP/S"; "specific productivity yield'; or "space-time-yield (STY)") are well known in the art and are determined as described for example by Song and Lee, 2006. "Carbon yield' and "YP/S" (each expressed in mass of organic compound produced/mass of assimilable carbon source consumed) are herein used as synonyms. The specific productivity yield describes the amount of a product, like succinic acid, that is produced per h and L fermentation broth per g of dry biomass. The amount of dry cell weight stated as "DCW describes the quantity of biologically active microorganism in a bio- chemical reaction. The value is given as g product per g DCW per h (i.e. g g DCW- ¹ h- ¹ ). The space-time-yield (STY) is defined as the ratio of the total amount of organic compound formed in the fermentation process to the volume of the culture, regarded over the entire time of cultivation. The space-time yield is also known as the "volumetric productivity. In process step II) the organic compound is recovered from the fermentation broth obtained in process step I).

Usually, the recovery process comprises the step of separating the recombinant microorganisms from the fermentation broth as the so called "biomass". Processes for removing the bio- mass are known to those skilled in the art, and comprise filtration, sedimentation, flotation or combinations thereof. Consequently, the biomass can be removed, for example, with centrifuges, separators, decanters, filters or in a flotation apparatus. For maximum recovery of the product of value, washing of the biomass is often advisable, for example in the form of a diafiltration. The selection of the method is dependent upon the biomass content in the fermentation broth and the properties of the biomass, and also the interaction of the biomass with the organic compound (e. the product of value). In one embodiment, the fermentation broth can be sterilized or pasteurized. In a further embodiment, the fermentation broth is concentrated. Depending on the requirement, this concentration can be done batch wise or continuously. The pressure and temperature range should be selected such that firstly no product damage occurs, and secondly minimal use of apparatus and energy is necessary. The skillful selection of pressure and temperature levels for a multistage evaporation in particular enables saving of energy.

The recovery process may further comprise additional purification steps in which the organic compound, preferably succinic acid, is further purified. If, however, the organic compound is converted into a secondary organic product by chemical reactions as described below, a further purification of the organic compound is, depending on the kind of reaction and the reaction con- ditions, not necessarily required. For the purification of the organic compound obtained in process step II), preferably for the purification of succinic acid, methods known to the person skilled in the art can be used, as for example crystallization, filtration, electrodialysis and chromatography. In the case of succinic acid as the organic compound, for example, succinic acid may be isolated by precipitating it as a calcium succinate product by using calcium hydroxide, -oxide, - carbonate or hydrogen carbonate for neutralization and filtration of the precipitate. The succinic acid is recovered from the precipitated calcium succinate by acidification with sulfuric acid followed by filtration to remove the calcium sulfate (gypsum) which precipitates. The resulting solution may be further purified by means of ion exchange chromatography in order to remove un- desired residual ions. Alternatively, if magnesium hydroxide, magnesium carbonate or mixtures thereof have been used to neutralize the fermentation broth, the fermentation broth obtained in process step I) may be acidified to transform the magnesium succinate contained in the medium into the acid form (i. e. succinic acid), which subsequently can be crystallized by cooling down the acidified medium. Examples of further suitable purification processes are disclosed in EP-A- 1 005 562, WO-A-2008/010373, WO-A-201 1/082378, WO-A-201 1/043443, WO-A- 2005/030973, WO-A-201 1/123268 and WO-A-201 1/064151 and EP-A-2 360 137.

According to a preferred embodiment of the process according to the present invention the process further comprises the process step: III) conversion of the organic compound contained in the fermentation broth obtained in process step I) or conversion of the recovered organic compound obtained in process step II) into a secondary organic product being different from the organic compound by at least one chemical reaction. In case of succinic acid as the organic compound preferred secondary organic products are selected from the group consisting of succinic acid esters and polymers thereof, tetrahydrofuran (THF), 1 ,4-butanediol (BDO), gamma-butyrolactone (GBL) and pyrrolidones.

According to a preferred embodiment for the production of THF, BDO and/or GBL this process comprises: b1 ) either the direct catalytic hydrogenation of the succinic acid obtained in process steps I) or II) to THF and/or BDO and/or GBL or b2) the chemical esterification of succinic acid and/or succinic acid salts obtained in process steps I) or II) into its corresponding di-lower alkyl ester and subsequent catalytic hydrogenation of said ester to THF and/or BDO and/or GBL.

According to a preferred embodiment for the production of pyrrolidones this process comprises: b) the chemical conversion of succinic acid ammonium salts obtained in process steps I) or II) to pyrrolidones in a manner known per se.

For details of preparing these compounds reference is made to US-A-2010/0159543 and WO- A-2010/092155.

A contribution to solving the problems mentioned at the outset is furthermore provided by the use of the modified microorganism according to the present invention for the fermentative production of organic compounds. Preferred organic compounds are those compounds that have already been mentioned in connection with the process according to the present invention, suc- cinic acid being the most preferred organic compound. Furthermore, preferred conditions for the fermentative production of organic compounds, preferably of succinic acid, are those conditions that have already been described in connection with process step I) of the process according to the present invention. The preferred assimilable carbon source that is used for the fermentative production of the organic compound, in particular for the fermentative production of succinic acid, is sucrose.

The invention is now explained in more detail with the aid of figures and non-limiting examples. Figure 1 shows a schematic map of plasmid pSacB (SEQ ID NO: 17).

Figure 2 shows a schematic map of plasmid pSacB AldhA (SEQ ID NO: 18). Figure 3 shows a schematic map of plasmid pSacB ApfIA (SEQ ID NO: 19). Figure 4 shows a schematic map of plasmid pSacB pykA1 (SEQ ID NO: 20). Figure 5 shows a schematic map of plasmid pSacB wcaJ ^* (SEQ ID NO: 21 ). Figure 6 shows a schematic map of plasmid pSacB AptsA (SEQ ID NO: 22).

Figure 7 shows a schematic map of plasmid pSacB AptsH (SEQ ID NO: 23). Examples

Example 1 : General method for the transformation of Basfia succiniciproducens

Strain

Wildtype DD1 (deposit DSM18541 )

DD1 MdhA

DD1 MdhA ApfIA

DD1 MdhA ApfIA pykA1

DD1 MdhA ApfIA pykA1 wcaJ*

DD1 MdhA ApfIA pykA1 wcaJ* AptsA

DD1 MdhA ApfIA pykA 1 wcaJ* AptsH

Table 1 : Nomenclature of the DD1 -wildtype and mutants referred to in the examples

Basfia succiniciproducens DD1 (wildtype) was transformed with DNA by electroporation using the following protocol:

For preparing a pre-culture DD1 was inoculated from frozen stock into 40 ml BHI (brain heart infusion; Becton, Dickinson and Company) in 100 ml shake flask. Incubation was performed over night at 37°C; 200 rpm. For preparing the main-culture 100 ml BHI were placed in a 250 ml shake flask and inoculated to a final OD (600 nm) of 0.2 with the pre-culture. Incubation was performed at 37°C, 200 rpm. The cells were harvested at an OD of approximately 0.5, 0.6 and 0.7, pellet was washed once with 10% cold glycerol at 4°C and re-suspended in 2 ml 10% glycerol (4°C).

100 μΙ of competent cells were the mixed with 2-8 μg Plasmid-DNA and kept on ice for 2 min in an electroporation cuvette with a width of 0.2 cm. Electroporation under the following conditions: 400 Ω; 25 \ F; 2.5 kV (Gene Pulser, Bio-Rad). 1 ml of chilled BHI was added immediately after electroporation and incubation was performed for approximately 2 h at 37°C.

Cells were plated on BHI with 5 mg/L chloramphenicol and incubated for 2-5 d at 37°C until the colonies of the transformants were visible. Clones were isolated and restreaked onto BHI with 5 mg/l chloramphenicol until purity of clones was obtained. Example 2: a) Generation of deletion constructs Deletion plasmids were constructed based on the vector pSacB (SEQ ID NO: 17). Figure

1 shows a schematic map of plasmid pSacB. 5'- and 3'- flanking regions (approx. 1500 bp each) of the chromosomal fragment, which should be deleted were amplified by PCR from chromosomal DNA of Basfia succiniciproducens and introduced into said vector using standard techniques. Normally, at least 80 % of the ORF were targeted for a deletion. In such a way, the deletion plasmids for the lactate dehydrogenase IdhA, pSacB_delta_/c/M

(SEQ ID NO: 18), the pyruvate formate lyase activating enzyme pfIA, pSacB_delta_ pfIA (SEQ ID NO: 19), the pfsA-gene, pSacB_delta_pfsA (SEQ ID NO: 22), and the pfsH-gene, pSacB_delta_pfsH (SEQ ID NO: 23). Figures 2, 3, 6 and 7 show schematic maps of plasmid pSacB_delta_WM, pSacB_delta_p/ZA, pSacB _delta_pfsA and pSacB _delta_pfsH, respectively.

In the plasmid sequence of pSacB (SEQ ID NO: 17) the sacB-gene is contained from bases 2380-3801 . The sacS-promotor is contained from bases 3802-4264. The chloramphenicol gene is contained from base 526-984. The origin of replication for E.coli (ori EC) is contained from base 1477-2337 (see fig. 1 ).

In the plasmid sequence of pSacB_delta_/c/M (SEQ ID NO: 18) the 5' flanking region of the IdhA gene, which is homologous to the genome of Basfia succiniciproducens, is contained from bases 1519-2850, while the 3' flanking region of the IdhA-gene, which is ho- mologous to the genome of Basfia succiniciproducens, is contained from bases 62-1518.

The sacB-gene is contained from bases 5169-6590. The sacS-promoter is contained from bases 6591 -7053. The chloramphenicol gene is contained from base 3315-3773. The origin of replication for E. coli (ori EC) is contained from base 4266-5126 (see fig. 2). In the plasmid sequence of pSacB_delta_pf/A (SEQ ID NO: 19) the 5' flanking region of the pflA-gene, which is homologous to the genome of Basfia succiniciproducens, is contained from bases 1506-3005, while the 3' flanking region of the pflA-gene, which is homologous to the genome of Basfia succiniciproducens, is contained from bases 6-1505. The sacB-gene is contained from bases 5278-6699. The sacS-promoter is contained from bases 6700-7162. The chloramphenicol gene is contained from base 3424-3882. The origin of replication for E. coli (ori EC) is contained from base 4375-5235 (see fig. 3).

In the plasmid sequence of pSacB_delta_pfsA (SEQ ID NO: 22) the 5' flanking region of the pfsA-gene, which is homologous to the genome of Basfia succiniciproducens, is con- tained from bases 1506-3005, while the 3' flanking region of the pfsA-gene, which is homologous to the genome of Basfia succiniciproducens, is contained from bases 6-1505. The sacB-gene is contained from bases 5278-6699. The sacS-promoter is contained from bases 6700-7162. The chloramphenicol gene is contained from base 3424-3882. The origin of replication for E. coli (ori EC) is contained from base 4375-5235 (see fig. 6).

In the plasmid sequence of pSacB_delta_pfsH (SEQ ID NO: 23) the 5' flanking region of the pfsH-gene, which is homologous to the genome of Basfia succiniciproducens, is contained from bases 1541 -3055, while the 3' flanking region of the pfsH-gene, which is homologous to the genome of Basfia succiniciproducens, is contained from bases 6-1540. The sacS-gene is contained from bases 5328-6749. The sacS-promoter is contained from bases 6750-7212. The chloramphenicol gene is contained from base 3474-3932. The origin of replication for E. coli (ori EC) is contained from base 4425-5285 (see fig. 7). b) Generation of constructs used for introduction of point mutations into the pykA-gene, and into the wcaJ-gene In the plasmid sequence of pSacB_py/o4i (SEQ ID NO: 20) the part of the pykA-gene, which is homologous to the genome of Basfia succiniciproducens, is contained from bases 6-1 185. The sacS-gene is contained from bases 3458-4879. The sacS-promoter is contained from bases 4880-5342. The chloramphenicol gene is contained from bases 1604-2062. The origin of replication for E. coli (ori EC) is contained from bases 2555-3415 (see fig. 4). The plasmid pSacB_pykA1 introduces G to T mutation in the pykA-gene which finally result in exchange of G (glycine) to C (cysteine) at position 167 in the PykA-protein (SEQ ID NO: 16).

In the plasmid sequence of pSacB_ivcaJ ^* (SEQ ID NO: 21 ) the 5' flanking region of the wcaJ-gene, which is homologous to the genome of Basfia succiniciproducens, is contained from bases 1838-3379, while the 3' flanking region of the wcaJ-gene, which is homologous to the genome of Basfia succiniciproducens, is contained from bases 6-1236. The sacS-gene is contained from bases 5652-7073. The sacS-promoter is contained from bases 7074-7536. The chloramphenicol gene is contained from bases 3798-4256. The origin of replication for E. coli (ori EC) is contained from bases 4749-5609. The wcaJ-gene is contained from bases 1237-1837 with an insertion of a nucleotide in the codon that encodes of lysine between thymine at position 81 and adenine at position 82 (which corresponds to position 1756 of plasmid pSacB_ivcaJ ^* , see fig. 5). This insertion leads to a frame shift mutation, wherein by means of this frame shift mutation a stop codon is intro- duced, leading to the expression of a truncated enzyme.

Example 3: Generation of improved succinate producing strains a) Basfia succiniciproducens DD1 was transformed as described above with the pSacB_delta_/c/M and "Campbelled in" to yield a "Campbell in" strain. Transformation and integration into the genome of Basfia succiniciproducens was confirmed by PCR yielding bands for the integrational event of the plasmid into the genome of Basfia succinicipro- ducens.

The "Campbell in" strain was then "Campbelled out" using agar plates containing sucrose as a counter selection medium, selecting for the loss (of function) of the sacB gene. Therefore, the "Campbell in" strains were incubated in 25-35 ml of non-selective medium (BHI containing no antibiotic) at 37°C, 220 rpm overnight. The overnight culture was then streaked onto freshly prepared BHI containing sucrose plates (10%, no antibiotics) and incubated overnight at 37°C ("first sucrose transfer"). Single colony obtained from first transfer were again streaked onto freshly prepared BHI containing sucrose plates (10%) and incubated overnight at 37°C ("second sucrose transfer"). This procedure was repeated until a minimal completion of five transfers ("third, forth, fifth sucrose transfer") in sucrose. The term "first to fifth sucrose transfer" refers to the transfer of a strain after chromosomal integration of a vector containing a sacB levan-sucrase gene onto sucrose and growth medium containing agar plates for the purpose of selecting for strains with the loss of the sacB gene and the surrounding plasmid sequences. Single colony from the fifth transfer plates were inoculated onto 25-35 ml of non selective medium (BHI containing no antibiotic) and incubated at 37°C, 220 rpm over night. The overnight culture was serially diluted and plated onto BHI plates to obtain isolated single colonies.

The "Campbelled out" strains containing the mutation/deletion of the IdhA-gene were confirmed by chloramphenicol sensitivity. The mutation/deletion mutants among these strains were identified and confirmed by PCR analysis. This led to the /c/M-deletion mutant Basfia succiniciproducens DD1 AldhA.

Basfia succiniciproducens AldhA was transformed with pSacB_delta_pf/A as described above and "Campbelled in" to yield a "Campbell in" strain. Transformation and integration was confirmed by PCR. The "Campbell in" strain was then "Campbelled out" as described previously. The deletion mutants among these strains were identified and confirmed by PCR analysis. This led to the IdhA pfIA double deletion mutant Basfia succiniciproducens DD1 AldhA ΔρΠΑ.

Basfia succiniciproducens AldhA ΔρίΙΑ was transformed with pSacB_pykA1 as described above and "Campbelled in" to yield a "Campbell in" strain. The "Campbell in" strain was then "Campbelled out" as described previously. The mutants among these strains were identified and confirmed by PCR analysis. This led to the mutant Basfia succiniciproducens DD1 AldhA ΔρΠΑ pykA1 in which IdhA and pfIA are deleted, and which expresses a pyruvate kinase in which at amino acid at position 167 glycine is substituted by cysteine.

Basfia succiniciproducens AldhA ΔρίΙΑ pykA1 was transformed with pSacB_ivcaJ ^* as described above and "Campbelled in" to yield a "Campbell in" strain. The "Campbell in" strain was then "Campbelled out" as described previously. The mutants among these strains were identified and confirmed by PCR analysis. This led to the mutant Basfia suc- ciniciproducens DD1 AldhA ΔρΠΑ pykA1 wcaJ* in which IdhA and pfIA are deleted, which expresses a pyruvate kinase in which at amino acid at position 167 glycine is substituted by cysteine, and which expresses a truncated enzyme encoded by the wcaJ-gene. e) Basfia succiniciproducens AldhA ApfIA pykA1 wcaJ ^* was transformed with

pSacB_delta_pfsA as described above and "Campbelled in" to yield a "Campbell in" strain. Transformation and integration was confirmed by PCR. The "Campbell in" strain was then "Campbelled out" as described previously. The deletion mutants among these strains were identified and confirmed by PCR analysis. This led to the mutant Basfia succiniciproducens DD1 AldhA ApfIA pykA1 wcaJ* AptsA f) Basfia succiniciproducens AldhA ApfIA pykA1 wcaJ ^* was transformed with

pSacB_delta_ ?Pr as described above and "Campbelled in" to yield a "Campbell in" strain. Transformation and integration was confirmed by PCR. The "Campbell in" strain was then

"Campbelled out" as described previously. The deletion mutants among these strains were identified and confirmed by PCR analysis. This led to the mutant Basfia succiniciproducens DD1 AldhA ApfIA pykA1 wcaJ'AptsH. Example 4: Cultivation of various DD1 -strains on glucose and sucrose

Productivity was analyzed utilizing media and incubation conditions described below.

1 . Medium preparation

The composition and preparation of the cultivation medium CGM is as described in the following table 2.

Table 2: Medium composition for cultivation on glucose (medium CGM)

The composition and preparation of the cultivation medium LSM_3 is as described in the following tables 3, 4, and 5. Trace element solution

Compound Final concentration citric acid 10 g/L

ZnS0 ₄ x 7 H ₂ 0 1851 mg/L

CaS0 ₄ x 2 H ₂ 0 10 mg/L

FeS0 ₄ x 7 H ₂ 0 2040 mg/L

CaCI ₂ x 2 H ₂ 0 12460 mg/L

MnCI ₂ x 4 H ₂ 0 1200 mg/L

Na ₂ Mo0 ₄ x 2 H ₂ 0 38 mg/L

CuCI ₂ x 2 H ₂ 0 188 mg/L

NiCI ₂ x 6 H ₂ 0 32 mg/L

CoCI ₂ x 6 H ₂ 0 101 mg/L

Table 3: Composition of trace element solution

Vitamin solution

Compound Final concentration

Thiamin HCI (B1 ) 1 .0 g/L

Nicotinic acid (B3) 1 .0 g/L

Riboflavin (B2) 20 mg/L

Biotin (B7) 50 mg/L

Pantothenic acid (B5) 1 .0 g/L

Pyridoxine (B6) 1 .0 g/L

Cyanocobalamin (B12) 50 mg/L

Lipoic acid 5 mg/L

Table 4: Composition of vitamin solution

Table 5: Composition of LSM_3 medium for cultivation on sucrose Cultivations and analytics

For growing the pre-culture bacteria from a freshly grown BHI-agar plate (incubated overnight at 37°C under anaerobic conditions) was used to inoculate to OD600 = 0.75 a 100 ml-serum bottle with gas tight butyl rubber stopper containing 50 ml of the CGM liquid medium described in table 2 with a C02-atmosphere. The bottles were incubated at 37°C and 170 rpm (shaking diameter: 2.5 cm). For growing the main culture 2.5 ml of the bacterial culture in the CGM medium (after 10 hours of incubation) was used to inoculate a 100 ml-serum bottle with gas tight butyl rubber stopper containing 50 ml of the LSM_3 liquid medium described in table 5 with a C02-atmosphere. Production of succinic acid was quantified via HPLC (HPLC methods are described in tables 7 and 8). Cell growth was measured by measuring the absorbance at 600 nm (OD600) using a spectrophotometer (Ultrospec3000, Amersham Biosciences, Uppsala Sweden).

Results

The results of the cultivation experiments with different DD1 -strains are shown in table 6.

Table 6: Cultivation of the DDM ldhAApflApykA1wcaJ ^* -s a\<c\, the

OOV^ldhAKpflApykAlwcaJ^ptsA-stiam and the OOV ldhA pflApykA1wcaJ ^* ptsH- strain on sucrose (medium LSM_3).

SA yield (ration of succinic acid per consumed substrate)

Table 7: HPLC method (ZX-THF50) for analysis of succinic acid HPLC column Fast Carbohydrate, 100 x 7.8 mm (Biorad)

Precolumn Deashing Refill Cartridges (30 °C)

Temperature 75 °C

Eluent flow rate 1 .00 ml/min

Injection volume 1 .0 μΙ

Diode array detector Rl-Detector

Runtime 8 min

max. pressure 150 bar

Eluent A water

Eluent B water

Time [min] A[%] B[%] Flow [ml/min]

Gradient 0.0 50 50 1 .00

8.0 50 50 1 .00

Table 8: HPLC method (Fast-CH) for analysis of sucrose

SEQUENCES

SEQ ID NO: 1 (nucleotide sequence of 16 S rDNA of strain DD1 )

tttgatcctggctcagattgaacgctggcggcaggcttaacacatgcaagtcgaacg gtagcgggaggaaagcttgctttctttgccga cgagtggcggacgggtgagtaatgcttggggatctggcttatggagggggataacgacgg gaaactgtcgctaataccgcgtaatat cttcggattaaagggtgggactttcgggccacccgccataagatgagcccaagtgggatt aggtagttggtggggtaaaggcctacc aagccgacgatctctagctggtctgagaggatgaccagccacactggaactgagacacgg tccagactcctacgggaggcagca gtggggaatattgcacaatggggggaaccctgatgcagccatgccgcgtgaatgaagaag gccttcgggttgtaaagttctttcggtg acgaggaaggtgtttgttttaataggacaagcaattgacgttaatcacagaagaagcacc ggctaactccgtgccagcagccgcggt aatacggagggtgcgagcgttaatcggaataactgggcgtaaagggcatgcaggcggact tttaagtgagatgtgaaagccccgg gcttaacctgggaattgcatttcagactgggagtctagagtactttagggaggggtagaa ttccacgtgtagcggtgaaatgcgtagag atgtggaggaataccgaaggcgaaggcagccccttgggaagatactgacgctcatatgcg aaagcgtggggagcaaacaggatt agataccctggtagtccacgcggtaaacgctgtcgatttggggattgggctttaggcctg gtgctcgtagctaacgtgataaatcgacc gcctggggagtacggccgcaaggttaaaactcaaatgaattgacgggggcccgcacaagc ggtggagcatgtggtttaattcgatg caacgcgaagaaccttacctactcttgacatccagagaatcctgtagagatacgggagtg ccttcgggagctctgagacaggtgctg catggctgtcgtcagctcgtgttgtgaaatgttgggttaagtcccgcaacgagcgcaacc cttatcctttgttgccagcatgtaaagatgg gaactcaaaggagactgccggtgacaaaccggaggaaggtggggatgacgtcaagtcatc atggcccttacgagtagggctaca cacgtgctacaatggtgcatacagagggcggcgataccgcgaggtagagcgaatctcaga aagtgcatcgtagtccggattggagt ctgcaactcgactccatgaagtcggaatcgctagtaatcgcaaatcagaatgttgcggtg aatacgttcccgggccttgtacacaccg cccgtcacaccatgggagtgggttgtaccagaagtagatagcttaaccttcggggggggc gtttaccacggtatgattcatgactggg gtgaagtcgtaacaaggtaaccgtaggggaacctgcgg

SEQ ID NO: 2 (nucleotide sequence of 23 S rDNA of strain DD1 )

agtaataacgaacgacacaggtataagaatacttgaggttgtatggttaagtgacta agcgtacaaggtggatgccttggcaatcaga ggcgaagaaggacgtgctaatctgcgaaaagcttgggtgagttgataagaagcgtctaac ccaagatatccgaatggggcaaccc agtagatgaagaatctactatcaataaccgaatccataggttattgaggcaaaccgggag aactgaaacatctaagtaccccgagg aaaagaaatcaaccgagattacgtcagtagcggcgagcgaaagcgtaagagccggcaagt gatagcatgaggattagaggaat cggctgggaagccgggcggcacagggtgatagccccgtacttgaaaatcattgtgtggta ctgagcttgcgagaagtagggcggga cacgagaaatcctgtttgaagaaggggggaccatcctccaaggctaaatactcctgattg accgatagtgaaccagtactgtgaagg aaaggcgaaaagaaccccggtgaggggagtgaaatagaacctgaaaccttgtacgtacaa gcagtgggagcccgcgagggtga ctgcgtaccttttgtataatgggtcagcgacttatattatgtagcgaggttaaccgaata ggggagccgaagggaaaccgagtcttaact gggcgtcgagttgcatgatatagacccgaaacccggtgatctagccatgggcaggttgaa ggttgggtaacactaactggaggacc gaaccgactaatgttgaaaaattagcggatgacctgtggctgggggtgaaaggccaatca aaccgggagatagctggttctccccg aaatctatttaggtagagccttatgtgaataccttcgggggtagagcactgtttcggcta gggggccatcccggcttaccaacccgatgc aaactgcgaataccgaagagtaatgcataggagacacacggcgggtgctaacgttcgtcg tggagagggaaacaacccagacc gccagctaaggtcccaaagtttatattaagtgggaaacgaagtgggaaggcttagacagc taggatgttggcttagaagcagccatc atttaaagaaagcgtaatagctcactagtcgagtcggcctgcgcggaagatgtaacgggg ctcaaatatagcaccgaagctgcggc atcaggcgtaagcctgttgggtaggggagcgtcgtgtaagcggaagaaggtggttcgaga gggctgctggacgtatcacgagtgcg aatgctgacataagtaacgataaaacgggtgaaaaacccgttcgccggaagaccaagggt tcctgtccaacgttaatcggggcag ggtgagtcggcccctaaggcgaggctgaagagcgtagtcgatgggaaacgggttaatatt cccgtacttgttataattgcgatgtggg gacggagtaggttaggttatcgacctgttggaaaaggtcgtttaagttggtaggtggagc gtttaggcaaatccggacgcttatcaaca ccgagagatgatgacgaggcgctaaggtgccgaagtaaccgataccacacttccaggaaa agccactaagcgtcagattataata aaccgtactataaaccgacacaggtggtcaggtagagaatactcaggcgcttgagagaac tcgggtgaaggaactaggcaaaata gcaccgtaacttcgggagaaggtgcgccggcgtagattgtagaggtatacccttgaaggt tgaaccggtcgaagtgacccgctggct gcaactgtttattaaaaacacagcactctgcaaacacgaaagtggacgtatagggtgtga tgcctgcccggtgctggaaggttaattg atggcgttatcgcaagagaagcgcctgatcgaagccccagtaaacggcggccgtaactat aacggtcctaaggtagcgaaattcctt gtcgggtaagttccgacctgcacgaatggcataatgatggccaggctgtctccacccgag actcagtgaaattgaaatcgccgtgaa gatgcggtgtacccgcggctagacggaaagaccccgtgaacctttactatagcttgacac tgaaccttgaattttgatgtgtaggatag gtgggaggctttgaagcggtaacgccagttatcgtggagccatccttgaaataccaccct ttaacgtttgatgttctaacgaagtgcccg gaacgggtactcggacagtgtctggtgggtagtttgactggggcggtctcctcccaaaga gtaacggaggagcacgaaggtttgcta atgacggtcggacatcgtcaggttagtgcaatggtataagcaagcttaactgcgagacgg acaagtcgagcaggtgcgaaagcag gtcatagtgatccggtggttctgaatggaagggccatcgctcaacggataaaaggtactc cggggataacaggctgataccgccca agagttcatatcgacggcggtgtttggcacctcgatgtcggctcatcacatcctggggct gaagtaggtcccaagggtatggctgttcgc catttaaagtggtacgcgagctgggtttaaaacgtcgtgagacagtttggtccctatctg ccgtgggcgttggagaattgagaggggct gctcctagtacgagaggaccggagtggacgcatcactggtgttccggttgtgtcgccaga cgcattgccgggtagctacatgcggaa gagataagtgctgaaagcatctaagcacgaaacttgcctcgagatgagttctcccagtat ttaatactgtaagggttgttggagacgac gacgtagataggccgggtgtgtaagcgttgcgagacgttgagctaaccggtactaattgc ccgagaggcttagccatacaacgctca agtgtttttggtagtgaaagttattacggaataagtaagtagtcagggaatcggct

SEQ ID NO: 3 (nucleotide sequence of pfsA-gene from strain DD1 )

atgatttcaggaatcccggcctcaccaggtatcgtttttggtaaagcgttagttctg aaagaggaaaaaattgtacttgatatgcaaaaa attgctgaagatcaagttgaaactgaagtagctcgtttttatgaaggccgtacggcggca gtggaacaattaagcgccattagagatc gtgcagagaaaactctcggtgaagaaaaagcggctatcttcgaaggtcatttaatgattc ttgaagatgaagagttggaagaagaaa tcattgattatttgcgttcaaacaaagtaaatgcgggcgttgcggcaagtaaaatcattg atcaacaagttgctatgcttgcggatattgat gatgagtacttaaaagaacgtgccggcgatattcgcgatatcggtaaccgtttaattaaa aatatcttaggcatgaaaattgtggatttgg gcgaaatcaatgaagagtcaatcttggttgcttatgacttaacgccatcagaaaccgcac aattgaatttagacaaagtattaggttttat tactgatatcggtggtcgtacttcacatacctctattatggcccgttcgctggaattacc ggcaattgtaggtacaaataatgcaaccgca atgattaacagcggtgattatttagtacttgatgcaatcaataacgctgtttatgtgaat ccggctcaagacgtgattgacggcttaaaag cccaacaagcaaaattagcggaagaaaaagcggaattagctaaattaaaagatttaccgg cagtaacattggacggtcaccgtgtt gaagtggtggcgaatatcggtacgattcgtgactgtgagggtgcggatcgtaacggtgcg gaaggtgtcggtttataccgtaccgagtt cctgttcatggatcgtgaccaactgccttcagaagaagaacaatttatcgcttataaaga agtggtagaagcgatgaacggtcgccag gtggtattacgtaccatggatattggtggagataaagaattaccttatatgaatctgcca aaagaaatgaatccgttcttaggctggcgtg cggttcgtatcgcattggatcgtcgcgaaatcttaaatgctcaattgcgtgcggtattac gtgcttccgcattcggtaaattagcggtaatgt tcccgatgattatttccgttgaagaaattcgcgaattgaaatccgttatcgaaactttaa aacaagaattacgcaccgaaggtaaagcct ttgatgaaaatattcaaatcggtgtaatgtgtgaaacgccgtcagctgcagtaaatgcaa aattcttagcaaaagaagtggacttcttca gtatcggtactaatgatttaactcaatatactttagcggttgaccgtggtaatgaaatga tttcacatttatataatccaatgtcaccttcagta ttaagtttaattaaacaggttattgacgcctctcataccgaaggcaaatggactggtatg tgcggtgagttagccggtgatgaaaaagc cactattttattattaggtatgggattagacgaattcagcatgagcgctatttccgttcc tcgtattaaaaaattggttcgtagtgttaattttgc cgaagcaaaagcattagcggataaagccctgcaattaccgactgctgccgaaattgaaaa attagttgctgattttttagctgaaaaaa cattaaattag SEQ ID NO: 4 (amino acid sequence of the enzyme encoded by the above ptsA-gene)

MISGIPASPGIVFGKALVLKEEKIVLDMQKIAEDQVETEVARFYEGRTAAVEQLSAI RDRAEKTLG EEKAAIFEGHLMILEDEELEEEIIDYLRSNKVNAGVAASKIIDQQVAMLADIDDEYLKER AGDIRDI GNRLIKNILGMKIVDLGEINEESILVAYDLTPSETAQLNLDKVLGFITDIGGRTSHTSIM ARSLELP AIVGTNNATAMINSGDYLVLDAINNAVYVNPAQDVIDGLKAQQAKLAEEKAELAKLKDLP AVTLD GHRVEVVANIGTIRDCEGADRNGAEGVGLYRTEFLFMDRDQLPSEEEQFIAYKEWEAMNG RQ VVLRTMDIGGDKELPYMNLPKEMNPFLGWRAVRIALDRREILNAQLRAVLRASAFGKLAV MFP MIISVEEIRELKSVIETLKQELRTEGKAFDENIQIGVMCETPSAAVNAKFLAKEVDFFSI GTNDLTQ YTLAVDRGNEMISHLYNPMSPSVLSLIKQVIDASHTEGKWTGMCGELAGDEKATILLLGM GLDE FSMSAISVPRIKKLVRSVNFAEAKALADKALQLPTAAEIEKLVADFLAEKTLN

SEQ ID NO: 5 (nucleotide sequence of ptsH-gene from strain DD1 )

atgtattcaaaagatgttgaaattacagctcctaacggcttacacactcgtccggct gcacaatttgtaaaagaagcaaaagcgtttgc atctgatgtaacagtgacttctgccggtaaaagtgcaagtgcgaaaagtttattcaaatt acaaactttaggcttaactcaaggaactgt aattacaatttcagctgaaggcgaagatgagcaaaatgctgttgaccatttagttgcatt aattcctacattagaataa

SEQ ID NO: 6 (amino acid sequence of the enzyme encoded by the above pfsH-gene)

MYSKDVEITAPNGLHTRPAAQFVKEAKAFASDVTVTSAGKSASAKSLFKLQTLGLTQGTV ITISA

EGEDEQNAVDHLVALIPTLE

SEQ ID NO: 7 (nucleotide sequence of IdhA-gene from strain DD1 )

ttgacaaaatcagtatgtttaaataaggagctaactatgaaagttgccgtttacagt actaaaaattatgatcgcaaacatctggatttgg cgaataaaaaatttaattttgagcttcatttctttgattttttacttgatgaacaaaccg cgaaaatggcggagggcgccgatgccgtctgta ttttcgtcaatgatgatgcgagccgcccggtgttaacaaagttggcgcaaatcggagtga aaattatcgctttacgttgtgccggttttaat aatgtggatttggaggcggcaaaagagctgggattaaaagtcgtacgggtgcctgcgtat tcgccggaagccgttgccgagcatgcg atcggattaatgctgactttaaaccgccgtatccataaggcttatcagcgtacccgcgat gcgaatttttctctggaaggattggtcggtttt aatatgttcggcaaaaccgccggagtgattggtacgggaaaaatcggcttggcggctatt cgcattttaaaaggcttcggtatggacgtt ctggcgtttgatccttttaaaaatccggcggcggaagcgttgggcgcaaaatatgtcggt ttagacgagctttatgcaaaatcccatgtta tcactttgcattgcccggctacggcggataattatcatttattaaatgaagcggctttta ataaaatgcgcgacggtgtaatgattattaata ccagccgcggcgttttaattgacagccgggcggcaatcgaagcgttaaaacggcagaaaa tcggcgctctcggtatggatgtttatg aaaatgaacgggatttgtttttcgaggataaatctaacgatgttattacggatgatgtat tccgtcgcctttcttcctgtcataatgtgctttttac cggtcatcaggcgtttttaacggaagaagcgctgaataatatcgccgatgtgactttatc gaatattcaggcggtttccaaaaatgcaac gtgcgaaaatagcgttgaaggctaa SEQ ID NO: 8 (amino acid sequence of LdhA from strain DD1 )

MTKSVCLNKELTMKVAVYSTKNYDRKHLDLANKKFNFELHFFDFLLDEQTAKMAEGADAV CIFV NDDASRPVLTKLAQIGVKIIALRCAGFNNVDLEAAKELGLKVVRVPAYSPEAVAEHAIGL MLTLN RRIHKAYQRTRDANFSLEGLVGFNMFGKTAGVIGTGKIGLAAIRILKGFGMDVLAFDPFK NPAAE ALGAKYVGLDELYAKSHVITLHCPATADNYHLLNEAAFNKMRDGVMIINTSRGVLIDSRA AI EAL KRQKIGALGMDVYENERDLFFEDKSNDVITDDVFRRLSSCHNVLFTGHQAFLTEEALNNI ADVT LSNIQAVSKNATCENSVEG SEQ ID NO: 9 (nucleotide sequence of pflA-gene from strain DD1 )

atgtcggttttaggacgaattcattcatttgaaacctgcgggacagttgacgggccg ggaatccgctttattttatttttacaaggctgcttaa tgcgttgtaaatactgccataatagagacacctgggatttgcacggcggtaaagaaattt ccgttgaagaattaatgaaagaagtggtg acctatcgccattttatgaacgcctcgggcggcggagttaccgcttccggcggtgaagct attttacaggcggaatttgtacgggactgg ttcagagcctgccataaagaaggaattaatacttgcttggataccaacggtttcgtccgt catcatgatcatattattgatgaattgattgat gacacggatcttgtgttgcttgacctgaaagaaatgaatgaacgggttcacgaaagcctg attggcgtgccgaataaaagagtgctcg aattcgcaaaatatttagcggatcgaaatcagcgtacctggatccgccatgttgtagtgc cgggttatacagatagtgacgaagatttgc acatgctggggaatttcattaaagatatgaagaatatcgaaaaagtggaattattacctt atcaccgtctaggcgcccataaatgggaa gtactcggcgataaatacgagcttgaagatgtaaaaccgccgacaaaagaattaatggag catgttaaggggttgcttgcaggctac gggcttaatgtgacatattag

SEQ ID NO: 10 (amino acid sequence of PflA from strain DD1 )

MSVLGRIHSFETCGTVDGPGIRFILFLQGCLMRCKYCHNRDTWDLHGGKEISVEELMKEV VTY RHFMNASGGGVTASGGEAI LQAEFVRDWFRACHKEGINTCLDTNGFVRHHDHIIDELIDDTDLV LLDLKEMNERVHESLIGVPNKRVLEFAKYLADRNQRTWIRHVWPGYTDSDEDLHMLGNFI KD MKNIEKVELLPYHRLGAHKWEVLGDKYELEDVKPPTKELMEHVKGLLAGYGLNVTY

SEQ ID NO: 11 (nucleotide sequence of pflD-gene from strain DD1 )

atggctgaattaacagaagctcaaaaaaaagcatgggaaggattcgttcccggtgaa tggcaaaacggcgtaaatttacgtgacttt atccaaaaaaactatactccgtatgaaggtgacgaatcattcttagctgatgcgactcct gcaaccagcgagttgtggaacagcgtga tggaaggcatcaaaatcgaaaacaaaactcacgcacctttagatttcgacgaacatactc cgtcaactatcacttctcacaagcctgg ttatatcaataaagatttagaaaaaatcgttggtcttcaaacagacgctccgttaaaacg tgcaattatgccgtacggcggtatcaaaat gatcaaaggttcttgcgaagtttacggtcgtaaattagatccgcaagtagaatttatttt caccgaatatcgtaaaacccataaccaagg cgtattcgacgtttatacgccggatattttacgctgccgtaaatcaggcgtgttaaccgg tttaccggatgcttacggtcgtggtcgtattatc ggtgactaccgtcgtttagcggtatacggtattgattacctgatgaaagataaaaaagcc caattcgattcattacaaccgcgtttggaa gcgggcgaagacattcaggcaactatccaattacgtgaagaaattgccgaacaacaccgc gctttaggcaaaatcaaagaaatgg cggcatcttacggttacgacatttccggccctgcgacaaacgcacaggaagcaatccaat ggacatattttgcttatctggcagcggtt aaatcacaaaacggtgcggcaatgtcattcggtcgtacgtctacattcttagatatctat atcgaacgtgacttaaaacgcggtttaatca ctgaacaacaggcgcaggaattaatggaccacttagtaatgaaattacgtatggttcgtt tcttacgtacgccggaatacgatcaattatt ctcaggcgacccgatgtgggcaaccgaaactatcgccggtatgggcttagacggtcgtcc gttggtaactaaaaacagcttccgcgt attacatactttatacactatgggtacttctccggaaccaaacttaactattctttggtc cgaacaattacctgaagcgttcaaacgtttctgt gcgaaagtatctattgatacttcctccgtacaatacgaaaatgatgacttaatgcgtcct gacttcaacaacgatgactatgcaatcgcat gctgcgtatcaccgatggtcgtaggtaaacaaatgcaattcttcggtgcgcgcgcaaact tagctaaaactatgttatacgcaattaac ggcggtatcgatgagaaaaatggtatgcaagtcggtcctaaaactgcgccgattacagac gaagtattgaatttcgataccgtaatcg aacgtatggacagtttcatggactggttggcgactcaatatgtaaccgcattgaacatca tccacttcatgcacgataaatatgcatatg aagcggcattgatggcgttccacgatcgcgacgtattccgtacaatggcttgcggtatcg cgggtctttccgtggctgcggactcattatc cgcaatcaaatatgcgaaagttaaaccgattcgcggcgacatcaaagataaagacggtaa tgtcgtggcctcgaatgttgctatcga cttcgaaattgaaggcgaatatccgcaattcggtaacaatgatccgcgtgttgatgattt agcggtagacttagttgaacgtttcatgaaa aaagttcaaaaacacaaaacttaccgcaacgcaactccgacacaatctatcctgactatc acttctaacgtggtatacggtaagaaa accggtaatactccggacggtcgtcgagcaggcgcgccattcggaccgggtgcaaaccca atgcacggtcgtgaccaaaaaggt gcggttgcttcacttacttctgtggctaaacttccgttcgcttacgcgaaagacggtatt tcatataccttctctatcgtaccgaacgcattag gtaaagatgacgaagcgcaaaaacgcaaccttgccggtttaatggacggttatttccatc atgaagcgacagtggaaggcggtcaa cacttgaatgttaacgttcttaaccgtgaaatgttgttagacgcgatggaaaatccggaa aaatacccgcaattaaccattcgtgtttcag gttacgcggttcgtttcaactcattaactaaagagcaacaacaagacgtcatcactcgta cgtttacacaatcaatgtaa

SEQ ID NO: 12 (amino acid of PfID from strain DD1 )

MAELTEAQKKAWEGFVPGEWQNGVNLRDFIQKNYTPYEGDESFLADATPATSELWNS VMEGI KIENKTHAPLDFDEHTPSTITSHKPGYINKDLEKIVGLQTDAPLKRAIMPYGGIKMIKGS CEVYGR KLDPQVEFIFTEYRKTHNQGVFDVYTPDILRCRKSGVLTGLPDAYGRGRIIGDYRRLAVY GIDYL MKDKKAQFDSLQPRLEAGEDIQATIQLREEIAEQHRALGKIKEMAASYGYDISGPATNAQ EAIQ WTYFAYLAAVKSQNGAAMSFGRTSTFLDIYIERDLKRGLITEQQAQELMDHLVMKLRMVR FLRT PEYDQLFSGDPMWATETIAGMGLDGRPLVTKNSFRVLHTLYTMGTSPEPNLTILWSEQLP EAF KRFCAKVSIDTSSVQYENDDLMRPDFNNDDYAIACCVSPMVVGKQMQFFGARANLAKTML YAI NGGIDEKNGMQVGPKTAPITDEVLNFDTVIERMDSFMDWLATQYVTALNIIHFMHDKYAY EAAL MAFHDRDVFRTMACGIAGLSVAADSLSAIKYAKVKPIRGDIKDKDGNWASNVAIDFEIEG EYPQ FGNNDPRVDDLAVDLVERFMKKVQKHKTYRNATPTQSILTITSNVVYGKKTGNTPDGRRA GAP FGPGANPMHGRDQKGAVASLTSVAKLPFAYAKDGISYTFSIVPNALGKDDEAQKRNLAGL MDG YFHHEATVEGGQHLNVNVLNREMLLDAMENPEKYPQLTIRVSGYAVRFNSLTKEQQQDVI TRT FTQSM

SEQ ID NO: 13(nucleotide sequence of wcaJ-gene from strain DD1 )

atgataaaacgccttttcgatattgttgtcgcattgatagcattgattttgttttcg cccttatatttgtttgtggcttataaggtaaaacaaaattt gggatcaccggtgttatttaaacaaacccgccccggattgcatggtaaaccctttgagat gattaagttcagaacaatgaaagacggc gcagatgaaaacggtaatattttgccggatgcggagcgcttaacacctttcggcaaaatg ttgcgcgctaccagtctggacgagttgcc ggaactttggaatgtattaaaaggtgatatgagtctggtggggccgcgtcctctactgat ggaatatttgccgctgtataacgaaagaca ggctaagcgccatgaagtgaaacccggaattaccggttatgcacaggtaaacggtcgcaa tgccatcagttgggagcagaaatttg aattggatgcctggtatgttgaacatcaatccttgtggctggatttgaaaattatcgcaa agaccatccaaaaagtgatcgcaaaagac gatattaatgcggcagatgatgccaccatgcctaaatttgaagggaataaaaaatcatga

SEQ ID NO: 14 (amino acid sequence of the enzyme encoded by the above wcaJ-gene) MIKRLFDIVVALIALILFSPLYLFVAYKVKQNLGSPVLFKQTRPGLHGKPFEMIKFRTMK DGADEN GNILPDAERLTPFGKMLRATSLDELPELWNVLKGDMSLVGPRPLLMEYLPLYNERQAKRH EVK PGITGYAQVNGRNAISWEQKFELDAWYVEHQSLWLDLKIIAKTIQKVIAKDDINAADDAT MPKFE GNKKS

SEQ ID NO: 15 (nucleotide sequence of pykA-gene from strain DD1 )

atgtccagaagattaagaagaacgaaaatcgtatgtacaatggggcctgcaacagac aaaggcaataatttagaaaaaatcattgc tgccggtgcaaacgttgtacgtatgaacttctcccacggtacgcccgaagatcatatcgg tcgtgctgaaaaagtacgtgaaatcgctc ataaattaggtaaacacgtagcaatcttaggtgacttacaaggccctaaaatccgtgttt ctacttttaaagaaggcaaaattttcttaaat atcggtgataaattcattttagacgcagagatgcctaaaggtgaaggtaaccaggaagcg gttggtttagactataaaacattaccgc aagatgtggttccgggcgatatcttattattagatgacggtcgagttcaattgaaagtat tggcaaccgaaggtgcaaaagtattcaccg aagtaacggtcggtggcccactatcaaataataaaggcattaacaaattaggcggcggtt tatctgccgatgcattaaccgaaaaag ataaagcggatatcattactgcggcgcgtatcggtgtggattaccttgccgtatctttcc cgcgttcaagcgcggatttaaactacgcccg tcaattagcaaaagatgcgggcttggatgcgaaaatcgttgcgaaagtagaacgtgccga aacagttgaaacggacgaagcaatg gacgatatcatcaatgcggcggacgtaatcatggttgcgcgcggtgacttaggtgttgaa atcggtgatccggaattagtcggtgttcag aaaaaattaatccgtcgttcacgtcagttaaatcgtgttgttattaccgcaactcaaatg atggaatcaatgattagtaatcctatgccgac tcgtgcggaagtaatggacgtagctaacgcagtattggacggtaccgatgcggtaatgct ttctgctgaaaccgcggctggtcaatatc cggcggaaactgttgcggcgatggcgaaagttgcgttaggtgcggagaaaatgccaagca ttaatgtgtctaaacaccgtatgaacg ttcaattcgagtctattgaagaatctgttgcgatgtctgcaatgtatgcggcaaaccaca tgagaggcgtagcggcgattatcacattaa caagtagcggtcgtactgctcgtttaatgtctcgcattagttccggtttaccaatctttg cattgtcacgtaacgaatctacattaaacttatgc gcattatatcgtggtgtgacaccggttcattttgataaagacagccgtacctcagaaggt gcgacagcggcggttcaattattaaaaga cgaaggtttcttagtgtctggcgatttagtgttattaactcagggcgacgcaagcagttc tagcggtactaacctttgccgtacattgattgtt gaataa

SEQ ID NO: 16(amino acid sequence of PykA from strain DD1 )

MSRRLRRTKIVCTMGPATDKGNNLEKIIAAGANVVRMNFSHGTPEDHIGRAEKVREIAHK LGKH VAI LGDLQGPKIRVSTFKEGKIFLNIGDKFILDAEMPKGEGNQEAVGLDYKTLPQDWPGDILL LD DGRVQLKVLATEGAKVFTEVTVGGPLSNNKGINKLGGGLSADALTEKDKADIITAARIGV DYLAV SFPRSSADLNYARQLAKDAGLDAKIVAKVERAETVETDEAMDDIINAADVIMVARGDLGV EIGDP ELVGVQKKLIRRSRQLNRVVITATQMMESMISNPMPTRAEVMDVANAVLDGTDAVMLSAE TAA GQYPAETVAAMAKVALGAEKMPSI NVSKH RM NVQFESI EESVAMSAMYAAN H M RGVAAI ITLT SSGRTARLMSRISSGLPIFALSRNESTLNLCALYRGVTPVHFDKDSRTSEGATAAVQLLK DEGF LVSGDLVLLTQGDASSSSGTNLCRTLIVE

SEQ ID NO: 17 (complete nucleotide sequence of plasmid pSacB)

tcgagaggcctgacgtcgggcccggtaccacgcgtcatatgactagttcggacctag ggatatcgtcgacatcgatgctcttctgcgtt aattaacaattgggatcctctagactccataggccgctttcctggctttgcttccagatg tatgctctcctccggagagtaccgtgactttatt ttcggcacaaatacaggggtcgatggataaatacggcgatagtttcctgacggatgatcc gtatgtaccggcggaagacaagctgca aacctgtcagatggagattgatttaatggcggatgtgctgagagcaccgccccgtgaatc cgcagaactgatccgctatgtgtttgcgg atgattggccggaataaataaagccgggcttaatacagattaagcccgtatagggtatta ttactgaataccaaacagcttacggagg acggaatgttacccattgagacaaccagactgccttctgattattaatatttttcactat taatcagaaggaataaccatgaattttacccg gattgacctgaatacctggaatcgcagggaacactttgccctttatcgtcagcagattaa atgcggattcagcctgaccaccaaactcg atattaccgctttgcgtaccgcactggcggagacaggttataagttttatccgctgatga tttacctgatctcccgggctgttaatcagtttcc ggagttccggatggcactgaaagacaatgaacttatttactgggaccagtcagacccggt ctttactgtctttcataaagaaaccgaaa cattctctgcactgtcctgccgttattttccggatctcagtgagtttatggcaggttata atgcggtaacggcagaatatcagcatgatacca gattgtttccgcagggaaatttaccggagaatcacctgaatatatcatcattaccgtggg tgagttttgacgggatttaacctgaacatca ccggaaatgatgattattttgccccggtttttacgatggcaaagtttcagcaggaaggtg accgcgtattattacctgtttctgtacaggttc atcatgcagtctgtgatggctttcatgcagcacggtttattaatacacttcagctgatgt gtgataacatactgaaataaattaattaattctg tatttaagccaccgtatccggcaggaatggtggctttttttttatattttaaccgtaatc tgtaatttcgtttcagactggttcaggatgagctcg cttggactcctgttgatagatccagtaatgacctcagaactccatctggatttgttcaga acgctcggttgccgccgggcgttttttattggtg agaatccaagcactagcggcgcgccggccggcccggtgtgaaataccgcacagatgcgta aggagaaaataccgcatcaggcg ctcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagcggt atcagctcactcaaaggcggtaatacggtt atccacagaatcaggggataacgcaggaaagaacatgtgagcaaaaggccagcaaaaggc caggaaccgtaaaaaggccgc gttgctggcgtttttccataggctccgcccccctgacgagcatcacaaaaatcgacgctc aagtcagaggtggcgaaacccgacagg actataaagataccaggcgtttccccctggaagctccctcgtgcgctctcctgttccgac cctgccgcttaccggatacctgtccgcctttc tcccttcgggaagcgtggcgctttctcatagctcacgctgtaggtatctcagttcggtgt aggtcgttcgctccaagctgggctgtgtgcac gaaccccccgttcagcccgaccgctgcgccttatccggtaactatcgtcttgagtccaac ccggtaagacacgacttatcgccactgg cagcagccactggtaacaggattagcagagcgaggtatgtaggcggtgctacagagttct tgaagtggtggcctaactacggctaca ctagaaggacagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaagag ttggtagctcttgatccggcaaacaaacc accgctggtagcggtggtttttttgtttgcaagcagcagattacgcgcagaaaaaaagga tctcaagaagatcctttgatcttttctacgg ggtctgacgctcagtggaacgaaaactcacgttaagggattttggtcatgagattatcaa aaaggatcttcacctagatccttttaaagg ccggccgcggccgccatcggcattttcttttgcgtttttatttgttaactgttaattgtc cttgttcaaggatgctgtctttgacaacagatgttttct tgcctttgatgttcagcaggaagctcggcgcaaacgttgattgtttgtctgcgtagaatc ctctgtttgtcatatagcttgtaatcacgacatt gtttcctttcgcttgaggtacagcgaagtgtgagtaagtaaaggttacatcgttaggatc aagatccatttttaacacaaggccagttttgtt cagcggcttgtatgggccagttaaagaattagaaacataaccaagcatgtaaatatcgtt agacgtaatgccgtcaatcgtcatttttgat ccgcgggagtcagtgaacaggtaccatttgccgttcattttaaagacgttcgcgcgttca atttcatctgttactgtgttagatgcaatcagc ggtttcatcacttttttcagtgtgtaatcatcgtttagctcaatcataccgagagcgccg tttgctaactcagccgtgcgttttttatcgctttgca gaagtttttgactttcttgacggaagaatgatgtgcttttgccatagtatgctttgttaa ataaagattcttcgccttggtagccatcttcagttcc agtgtttgcttcaaatactaagtatttgtggcctttatcttctacgtagtgaggatctct cagcgtatggttgtcgcctgagctgtagttgccttc atcgatgaactgctgtacattttgatacgtttttccgtcaccgtcaaagattgatttata atcctctacaccgttgatgttcaaagagctgtctg atgctgatacgttaacttgtgcagttgtcagtgtttgtttgccgtaatgtttaccggaga aatcagtgtagaataaacggatttttccgtcaga tgtaaatgtggctgaacctgaccattcttgtgtttggtcttttaggatagaatcatttgc atcgaatttgtcgctgtctttaaagacgcggccag cgtttttccagctgtcaatagaagtttcgccgactttttgatagaacatgtaaatcgatg tgtcatccgcatttttaggatctccggctaatgc aaagacgatgtggtagccgtgatagtttgcgacagtgccgtcagcgttttgtaatggcca gctgtcccaaacgtccaggccttttgcaga agagatatttttaattgtggacgaatcaaattcagaaacttgatatttttcatttttttg ctgttcagggatttgcagcatatcatggcgtgtaata tgggaaatgccgtatgtttccttatatggcttttggttcgtttctttcgcaaacgcttga gttgcgcctcctgccagcagtgcggtagtaaagg ttaatactgttgcttgttttgcaaactttttgatgttcatcgttcatgtctcctttttta tgtactgtgttagcggtctgcttcttccagccctcctgtttga agatggcaagttagttacgcacaataaaaaaagacctaaaatatgtaaggggtgacgcca aagtatacactttgccctttacacatttt aggtcttgcctgctttatcagtaacaaacccgcgcgatttacttttcgacctcattctat tagactctcgtttggattgcaactggtctattttcct cttttgtttgatagaaaatcataaaaggatttgcagactacgggcctaaagaactaaaaa atctatctgtttcttttcattctctgtattttttata gtttctgttgcatgggcataaagttgcctttttaatcacaattcagaaaatatcataata tctcatttcactaaataatagtgaacggcaggt atatgtgatgggttaaaaaggatcggcggccgctcgatttaaatc

SEQ ID NO: 18 (complete nucleotide sequence of plasmid pSacB_delta_/c/M)

tcgagaggcctgacgtcgggcccggtaccacgcgtcatatgactagttcggacctag ggatgggtcagcctgaacgaaccgcactt gtatgtaggtagttttgaccgcccgaatattcgttataccttggtggaaaaattcaaacc gatggagcaattatacaattttgtggcggcgc aaaaaggtaaaagcggtatcgtctattgcaacagccgtagcaaagtggagcgcattgcgg aagccctgaagaaaagaggcatttc cgcagccgcttatcatgcgggcatggagccgtcgcagcgggaagcggtgcaacaggcgtt tcaacgggataatattcaagtggtgg tggcgaccattgcttttggtatggggatcaacaaatctaatgtgcgttttgtggcgcatt ttgatttatctcgcagcattgaggcgtattatcag gaaaccgggcgcgcggggcgggacgacctgccggcggaagcggtactgttttacgagccg gcggattatgcctggttgcataaaat tttattggaagagccggaaagcccgcaacgggatattaaacggcataagctggaagccat cggcgaatttgccgaaagccagacc tgccgtcgtttagtgctgttaaattatttcggcgaaaaccgccaaacgccatgtaataac tgtgatatctgcctcgatccgccgaaaaaat atgacggattattagacgcgcagaaaatcctttcgaccatttatcgcaccgggcaacgtt tcggcacgcaatacgtaatcggcgtaatg cgcggtttgcagaatcagaaaataaaagaaaatcaacatgatgagttgaaagtctacgga attggcaaagataaaagcaaagaat actggcaatcggtaattcgtcagctgattcatttgggctttgtgcaacaaatcatcagcg atttcggcatggggaccagattacagctcac cgaaagcgcgcgtcccgtgctgcgcggcgaagtgtctttggaactggccatgccgagatt atcttccattaccatggtacaggctccgc aacgcaatgcggtaaccaactacgacaaagatttatttgcccgcctgcgtttcctgcgca aacagattgccgacaaagaaaacattc cgccttatattgtgttcagtgacgcgaccttgcaggaaatgtcgttgtatcagccgacca gcaaagtggaaatgctgcaaatcaacggt gtcggcgccatcaaatggcagcgcttcggacagccttttatggcgattattaaagaacat caggctttgcgtaaagcgggtaagaatc cgttggaattgcaatcttaaaatttttaactttttgaccgcacttttaaggttagcaaat tccaataaaaagtgcggtgggttttcgggaattttt aacgcgctgatttcctcgtcttttcaatttyttcgyctccatttgttcggyggttgccgg atcctttcttgactgagatccataagagagtagaa tagcgccgcttatatttttaatagcgtacctaatcgggtacgctttttttatgcggaaaa tccatatttttctaccgcactttttctttaaagatttat acttaagtctgtttgattcaatttatttggaggttttatgcaacacattcaactggctcc cgatttaacattcagtcgcttaattcaaggattctg gcggttaaaaagctggcggaaatcgccgcaggaattgcttacattcgttaagcaaggatt agaattaggcgttgatacgctggatcat gccgcttgttacggggcttttacttccgaggcggaattcggacgggcgctggcgctggat aaatccttgcgcgcacagcttactttggtg accaaatgcgggattttgtatcctaatgaagaattacccgatataaaatcccatcactat gacaacagctaccgccatattatgtggtcg gcgcaacgttccattgaaaaactgcaatgcgactatttagatgtattgctgattcaccgw ctttctccctgtgcggatcccgaacaaatcg cgcgggcttttgatgaactttatcaaaccggraaagtacgttatttcggggtatctaact atacgccggctaagttcgccatgttgcaatctt atgtgaatcagccgttaatcactaatcaaattgagatttcgcctcttcatcgtcaggctt ttgatgacggtaccctggattttttactggaaaa acgtattcaaccgatggcatggtcgccacttgccggcggtcgtttattcaatcaggatga gaacagtcgggcggtgcaaaaaacatta ctcgaaatcggtgaaacgaaaggagaaacccgtttagatacattggcttatgcctggtta ttggcgcatccggcaaaaattatgccggt tatggggtccggtaaaattgaacgggtaaaaagcgcggcggatgcgttacgaatttcctt cactgaggaagaatggattaaggtttatg ttgccgcacagggacgggatattccgtaacatcatccgtctaatcctgcgtatctgggga aagatgcgtcatcgtaagaggtctataat attcgtcgttttgataagggtgccatatccggcacccgttaaaatcacattgcgttcgca acaaaattattccttacgaatagcattcacct cttttaacagatgttgaatatccgtatcggcaaaaatatcctctatatttgcggttaaac ggcgccgccagttagcatattgagtgctggttc ccggaatattgacgggttcggtcataccgagccagtcttcaggttggaatccccatcgtc gacatcgatgctcttctgcgttaattaacaa ttgggatcctctagactccataggccgctttcctggctttgcttccagatgtatgctctc ctccggagagtaccgtgactttattttcggcaca aatacaggggtcgatggataaatacggcgatagtttcctgacggatgatccgtatgtacc ggcggaagacaagctgcaaacctgtca gatggagattgatttaatggcggatgtgctgagagcaccgccccgtgaatccgcagaact gatccgctatgtgtttgcggatgattggc cggaataaataaagccgggcttaatacagattaagcccgtatagggtattattactgaat accaaacagcttacggaggacggaatg ttacccattgagacaaccagactgccttctgattattaatatttttcactattaatcaga aggaataaccatgaattttacccggattgacct gaatacctggaatcgcagggaacactttgccctttatcgtcagcagattaaatgcggatt cagcctgaccaccaaactcgatattaccg ctttgcgtaccgcactggcggagacaggttataagttttatccgctgatgatttacctga tctcccgggctgttaatcagtttccggagttcc ggatggcactgaaagacaatgaacttatttactgggaccagtcagacccggtctttactg tctttcataaagaaaccgaaacattctctg cactgtcctgccgttattttccggatctcagtgagtttatggcaggttataatgcggtaa cggcagaatatcagcatgataccagattgtttc cgcagggaaatttaccggagaatcacctgaatatatcatcattaccgtgggtgagttttg acgggatttaacctgaacatcaccggaaa tgatgattattttgccccggtttttacgatggcaaagtttcagcaggaaggtgaccgcgt attattacctgtttctgtacaggttcatcatgca gtctgtgatggctttcatgcagcacggtttattaatacacttcagctgatgtgtgataac atactgaaataaattaattaattctgtatttaagc caccgtatccggcaggaatggtggctttttttttatattttaaccgtaatctgtaatttc gtttcagactggttcaggatgagctcgcttggactc ctgttgatagatccagtaatgacctcagaactccatctggatttgttcagaacgctcggt tgccgccgggcgttttttattggtgagaatcca agcactagcggcgcgccggccggcccggtgtgaaataccgcacagatgcgtaaggagaaa ataccgcatcaggcgctcttccgct tcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagcggtatcagctcac tcaaaggcggtaatacggttatccacaga atcaggggataacgcaggaaagaacatgtgagcaaaaggccagcaaaaggccaggaaccg taaaaaggccgcgttgctggcg tttttccataggctccgcccccctgacgagcatcacaaaaatcgacgctcaagtcagagg tggcgaaacccgacaggactataaag ataccaggcgtttccccctggaagctccctcgtgcgctctcctgttccgaccctgccgct taccggatacctgtccgcctttctcccttcgg gaagcgtggcgctttctcatagctcacgctgtaggtatctcagttcggtgtaggtcgttc gctccaagctgggctgtgtgcacgaaccccc cgttcagcccgaccgctgcgccttatccggtaactatcgtcttgagtccaacccggtaag acacgacttatcgccactggcagcagcc actggtaacaggattagcagagcgaggtatgtaggcggtgctacagagttcttgaagtgg tggcctaactacggctacactagaagg acagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaagagttggtagc tcttgatccggcaaacaaaccaccgctggt agcggtggtttttttgtttgcaagcagcagattacgcgcagaaaaaaaggatctcaagaa gatcctttgatcttttctacggggtctgacg ctcagtggaacgaaaactcacgttaagggattttggtcatgagattatcaaaaaggatct tcacctagatccttttaaaggccggccgc ggccgccatcggcattttcttttgcgtttttatttgttaactgttaattgtccttgttca aggatgctgtctttgacaacagatgttttcttgcctttgat gttcagcaggaagctcggcgcaaacgttgattgtttgtctgcgtagaatcctctgtttgt catatagcttgtaatcacgacattgtttcctttcg cttgaggtacagcgaagtgtgagtaagtaaaggttacatcgttaggatcaagatccattt ttaacacaaggccagttttgttcagcggctt gtatgggccagttaaagaattagaaacataaccaagcatgtaaatatcgttagacgtaat gccgtcaatcgtcatttttgatccgcggga gtcagtgaacaggtaccatttgccgttcattttaaagacgttcgcgcgttcaatttcatc tgttactgtgttagatgcaatcagcggtttcatc acttttttcagtgtgtaatcatcgtttagctcaatcataccgagagcgccgtttgctaac tcagccgtgcgttttttatcgctttgcagaagttttt gactttcttgacggaagaatgatgtgcttttgccatagtatgctttgttaaataaagatt cttcgccttggtagccatcttcagttccagtgtttg cttcaaatactaagtatttgtggcctttatcttctacgtagtgaggatctctcagcgtat ggttgtcgcctgagctgtagttgccttcatcgatg aactgctgtacattttgatacgtttttccgtcaccgtcaaagattgatttataatcctct acaccgttgatgttcaaagagctgtctgatgctga tacgttaacttgtgcagttgtcagtgtttgtttgccgtaatgtttaccggagaaatcagt gtagaataaacggatttttccgtcagatgtaaat gtggctgaacctgaccattcttgtgtttggtcttttaggatagaatcatttgcatcgaat ttgtcgctgtctttaaagacgcggccagcgtttttc cagctgtcaatagaagtttcgccgactttttgatagaacatgtaaatcgatgtgtcatcc gcatttttaggatctccggctaatgcaaagac gatgtggtagccgtgatagtttgcgacagtgccgtcagcgttttgtaatggccagctgtc ccaaacgtccaggccttttgcagaagagat atttttaattgtggacgaatcaaattcagaaacttgatatttttcatttttttgctgttc agggatttgcagcatatcatggcgtgtaatatgggaa atgccgtatgtttccttatatggcttttggttcgtttctttcgcaaacgcttgagttgcg cctcctgccagcagtgcggtagtaaaggttaatact gttgcttgttttgcaaactttttgatgttcatcgttcatgtctccttttttatgtactgt gttagcggtctgcttcttccagccctcctgtttgaagatgg caagttagttacgcacaataaaaaaagacctaaaatatgtaaggggtgacgccaaagtat acactttgccctttacacattttaggtctt gcctgctttatcagtaacaaacccgcgcgatttacttttcgacctcattctattagactc tcgtttggattgcaactggtctattttcctcttttgttt gatagaaaatcataaaaggatttgcagactacgggcctaaagaactaaaaaatctatctg tttcttttcattctctgtattttttatagtttctgt tgcatgggcataaagttgcctttttaatcacaattcagaaaatatcataatatctcattt cactaaataatagtgaacggcaggtatatgtg atgggttaaaaaggatcggcggccgctcgatttaaatc

SEQ ID NO: 19 (complete nucleotide sequence of plasmid pSacB_delta_pf/A)

tcgagtcaatgcggatttgacttatgatgtggcaaacaaccgatttccgattattac tacacgtaaaagttattggaaagcggcgattgcg gagtttctgggttatatccgcggctacgataatgcggcggatttccgtaaattaggagca aaaacctgggatgccaacgctaatgaaa atcaggtatggctgaataaccctcatcgcaaaggcaccgacgacatggggcgcgtttacg gcgtacagggcagagcctggcgtaa gcctaacggcgaaaccgttgatcaattacgcaaaattgtcaacaatttaagtcgcggcat tgatgatcgcggcgaaattctgaccttttt aaacccgggcgaattcgatctcggttgtctgcgcccttgtatgtacaatcacacgttttc tttgctgggcgatacgctttatttaaccagttat caacgctcctgtgacgtacctttaggcttgaatttcaatcaaattcaagtatttacattc ttagctttaatggcgcagattaccggtaaaaaa gccggtcaggcatatcacaaaatcgtcaatgcgcatatttacgaagaccagctggaacta atgcgcgacgtgcagttaaaacgcga accgttcccgtcgccaaaactggaaattaatccggacattaaaacccttgaagatttaga aacctgggtaaccatggatgatttcaacg tcgttggttaccaatgccacgaaccgataaaatatccgttctcggtataaaccgacaaaa gtgcggtcaaaaatttaatattttcatctgtt atagaaaatatttttcaacataaaatctagggatgcctgtttggcgtccgtaaatacgca gaaaaatattaaatttttgaccgcacttttttc atctcaattaacagcctgataattcttatggatcaacaaattagctttgacgaaaaaatg atgaatcgagctcttttccttgccgacaagg cggaagctttaggggaaattcccgtaggtgccgtattggtggatgaacggggcaatatca ttggtgaaggctggaacctctctattgtg aactcggatcccaccgcccatgccgaaattattgcgttgcgtaacgccgcgcagaaaatc caaaattaccgcctgctcaataccactt tatacgtgactttagaaccctgcaccatgtgcgccggcgcgattttacacagccgaatca aacgcttggtattcggggcgtccgattac aaaaccggtgcggtgggttccagatttcatttttttgaggattataaaatgaatcatggg gttgagatcacaagcggtgtcttacaggatc aatgcagtcagaagttaagccgctttttccaaaagcgcagggaacagaaaaaacaacaaa aagctaccgcacttttacaacaccc ccggcttaactcctctgaaaaatagtgacaaaaaaaccgtcataatgtttacgacggttt ttttatttcttaatatgcccttaaataatcaac aaaatatagcaagaagattatagcaaagaatttcgtttttttcagagaatagtcaaatct tcgcaaaaaactaccgcacttttatccgcttt aatcaggggaattaaaacaaaaaaattccgcctattgaggcggaatttattaagcaataa gacaaactctcaattacattgattgtgta aacgtacgagtgatgacgtcttgttgttgctctttagttaatgagttgaaacgaaccgcg taacctgaaacacgaatggttaattgcgggt atttttccggattttccatcgcgtctaacaacatttcacggttaagaacgttaacattca agtgttgaccgccttccactgtcgcttcatgatg gaaataaccgtccattaaaccggcaaggttgcgtttttgcgcttcgtcatctttacctaa tgcgttcggtacgatagagaaggtatatgaa ataccgtctttcgcgtaagcgaacggaagtttagccacagaagtaagtgaagcaaccgca cctttttggtcacgaccgtgcattgggttt gcacccggtccgaatggcgcgcctgctcgacgaccgtccggagtattaccggttttctta ccgtataccacgttagaagtgatagtcag gatagattgtgtcggagttgcgttgcggtaagttttgtgtttttgaacttttttcatgaa acgttcaactaagtctaccgctaaatcatcaacac gcggatcattgttaccgaattgcggatattcgccttcaatttcgaagtcgatagcaacat tcgaggccacgacattaccgtctttatctttga tgtcgccgcgaatcggtttaactttcgcatatttgattgcggataatgagtccgcagcca cggaaagacccgcgataccgcaagccatt gtacggaatacgtcgcgatcgtggaacgccatcaatgccgcttcatatgcatatttatcg tgcatgaagtggatgatgttcaatgcggtta catattgagtcgccaaccagtccatgaaactgtccatacgttcgattacggtatcgaaat tcaatacttcgtctgtaatcggcgcagtttta ggaccgacttgcataccatttttctcatcgataccgccgttaattgcgtataacatagtt ttagctaagtttgcgcgcgcaccgaagaattg catttgtttacctacgaccatcggtgatacgcagcatgcgattgcatagtcatcgttgtt gaagtcaggacgcattaagtcatcattttcgta ttgtacggaggaagtatcaatagatactttcgcacagaaacgtttgaacgcttcaggtaa ttgttcggaccaaagaatagttaagtttggt tccggagaagtacccatagtgtataaagtatgtaatacgcggaagctgtttttagttacc aacggacgaccgtctaagcccataccggc gatagtttcggttgccctctagactccataggccgctttcctggctttgcttccagatgt atgctctcctccggagagtaccgtgactttattttc ggcacaaatacaggggtcgatggataaatacggcgatagtttcctgacggatgatccgta tgtaccggcggaagacaagctgcaaa cctgtcagatggagattgatttaatggcggatgtgctgagagcaccgccccgtgaatccg cagaactgatccgctatgtgtttgcggat gattggccggaataaataaagccgggcttaatacagattaagcccgtatagggtattatt actgaataccaaacagcttacggaggac ggaatgttacccattgagacaaccagactgccttctgattattaatatttttcactatta atcagaaggaataaccatgaattttacccggat tgacctgaatacctggaatcgcagggaacactttgccctttatcgtcagcagattaaatg cggattcagcctgaccaccaaactcgata ttaccgctttgcgtaccgcactggcggagacaggttataagttttatccgctgatgattt acctgatctcccgggctgttaatcagtttccgg agttccggatggcactgaaagacaatgaacttatttactgggaccagtcagacccggtct ttactgtctttcataaagaaaccgaaaca ttctctgcactgtcctgccgttattttccggatctcagtgagtttatggcaggttataat gcggtaacggcagaatatcagcatgataccag attgtttccgcagggaaatttaccggagaatcacctgaatatatcatcattaccgtgggt gagttttgacgggatttaacctgaacatcac cggaaatgatgattattttgccccggtttttacgatggcaaagtttcagcaggaaggtga ccgcgtattattacctgtttctgtacaggttcat catgcagtctgtgatggctttcatgcagcacggtttattaatacacttcagctgatgtgt gataacatactgaaataaattaattaattctgta tttaagccaccgtatccggcaggaatggtggctttttttttatattttaaccgtaatctg taatttcgtttcagactggttcaggatgagctcgctt ggactcctgttgatagatccagtaatgacctcagaactccatctggatttgttcagaacg ctcggttgccgccgggcgttttttattggtgag aatccaagcactagcggcgcgccggccggcccggtgtgaaataccgcacagatgcgtaag gagaaaataccgcatcaggcgctc ttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagcggtatc agctcactcaaaggcggtaatacggttatc cacagaatcaggggataacgcaggaaagaacatgtgagcaaaaggccagcaaaaggccag gaaccgtaaaaaggccgcgtt gctggcgtttttccataggctccgcccccctgacgagcatcacaaaaatcgacgctcaag tcagaggtggcgaaacccgacaggac tataaagataccaggcgtttccccctggaagctccctcgtgcgctctcctgttccgaccc tgccgcttaccggatacctgtccgcctttctc ccttcgggaagcgtggcgctttctcatagctcacgctgtaggtatctcagttcggtgtag gtcgttcgctccaagctgggctgtgtgcacg aaccccccgttcagcccgaccgctgcgccttatccggtaactatcgtcttgagtccaacc cggtaagacacgacttatcgccactggc agcagccactggtaacaggattagcagagcgaggtatgtaggcggtgctacagagttctt gaagtggtggcctaactacggctacac tagaaggacagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaagagt tggtagctcttgatccggcaaacaaacca ccgctggtagcggtggtttttttgtttgcaagcagcagattacgcgcagaaaaaaaggat ctcaagaagatcctttgatcttttctacggg gtctgacgctcagtggaacgaaaactcacgttaagggattttggtcatgagattatcaaa aaggatcttcacctagatccttttaaaggc cggccgcggccgccatcggcattttcttttgcgtttttatttgttaactgttaattgtcc ttgttcaaggatgctgtctttgacaacagatgttttctt gcctttgatgttcagcaggaagctcggcgcaaacgttgattgtttgtctgcgtagaatcc tctgtttgtcatatagcttgtaatcacgacattg tttcctttcgcttgaggtacagcgaagtgtgagtaagtaaaggttacatcgttaggatca agatccatttttaacacaaggccagttttgttc agcggcttgtatgggccagttaaagaattagaaacataaccaagcatgtaaatatcgtta gacgtaatgccgtcaatcgtcatttttgatc cgcgggagtcagtgaacaggtaccatttgccgttcattttaaagacgttcgcgcgttcaa tttcatctgttactgtgttagatgcaatcagc ggtttcatcacttttttcagtgtgtaatcatcgtttagctcaatcataccgagagcgccg tttgctaactcagccgtgcgttttttatcgctttgca gaagtttttgactttcttgacggaagaatgatgtgcttttgccatagtatgctttgttaa ataaagattcttcgccttggtagccatcttcagttcc agtgtttgcttcaaatactaagtatttgtggcctttatcttctacgtagtgaggatctct cagcgtatggttgtcgcctgagctgtagttgccttc atcgatgaactgctgtacattttgatacgtttttccgtcaccgtcaaagattgatttata atcctctacaccgttgatgttcaaagagctgtctg atgctgatacgttaacttgtgcagttgtcagtgtttgtttgccgtaatgtttaccggaga aatcagtgtagaataaacggatttttccgtcaga tgtaaatgtggctgaacctgaccattcttgtgtttggtcttttaggatagaatcatttgc atcgaatttgtcgctgtctttaaagacgcggccag cgtttttccagctgtcaatagaagtttcgccgactttttgatagaacatgtaaatcgatg tgtcatccgcatttttaggatctccggctaatgc aaagacgatgtggtagccgtgatagtttgcgacagtgccgtcagcgttttgtaatggcca gctgtcccaaacgtccaggccttttgcaga agagatatttttaattgtggacgaatcaaattcagaaacttgatatttttcatttttttg ctgttcagggatttgcagcatatcatggcgtgtaata tgggaaatgccgtatgtttccttatatggcttttggttcgtttctttcgcaaacgcttga gttgcgcctcctgccagcagtgcggtagtaaagg ttaatactgttgcttgttttgcaaactttttgatgttcatcgttcatgtctcctttttta tgtactgtgttagcggtctgcttcttccagccctcctgtttga agatggcaagttagttacgcacaataaaaaaagacctaaaatatgtaaggggtgacgcca aagtatacactttgccctttacacatttt aggtcttgcctgctttatcagtaacaaacccgcgcgatttacttttcgacctcattctat tagactctcgtttggattgcaactggtctattttcct cttttgtttgatagaaaatcataaaaggatttgcagactacgggcctaaagaactaaaaa atctatctgtttcttttcattctctgtattttttata gtttctgttgcatgggcataaagttgcctttttaatcacaattcagaaaatatcataata tctcatttcactaaataatagtgaacggcaggt atatgtgatgggttaaaaaggatcggcggccgctcgatttaaatc

SEQ ID NO: 20 (complete nucleotide sequence of plasmid pSacB_py/oAi)

tcgagcagaagattaagaagaacgaaaatcgtatgtacaatggggcctgcaacagac aaaggcaataatttagaaaaaatcattg ctgccggtgcaaacgttgtacgtatgaacttctcccacggtacgcccgaagatcatatcg gtcgtgctgaaaaagtacgtgaaatcgct cataaattaggtaaacacgtagcaatcttaggtgacttacaaggccctaaaatccgtgtt tctacttttaaagaaggcaaaattttcttaaa tatcggtgataaattcattttagacgcagagatgcctaaaggtgaaggtaaccaggaagc ggttggtttagactataaaacattaccgc aagatgtggttccgggcgatatcttattattagatgacggtcgagttcaattgaaagtat tggcaaccgaaggtgcaaaagtattcaccg aagtaacggtcggtggcccactatcaaataataaaggcattaacaaattaggcggcggtt tatctgccgatgcattaaccgaaaaag ataaagcggatatcattactgcggcgcgtatcggtgtggattaccttgccgtatctttcc cgcgttcaagcgcggatttaaactacgcccg tcaattagcaaaagatgcgggcttggatgcgaaaatcgttgcgaaagtagaacgtgccga aacagttgaaacggacgaagcaatg gacgatatcatcaatgcggcggacgtaatcatggttgcgcgcggtgacttaggtgttgaa atcggtgatccggaattagtcggtgttcag aaaaaattaatccgtcgttcacgtcagttaaatcgtgttgttattaccgcaactcaaatg atggaatcaatgattagtaatcctatgccgac tcgtgcggaagtaatggacgtagctaacgcagtattggacggtaccgatgcggtaatgct ttctgctgaaaccgcggctggtcaatatc cggcggaaactgttgcggcgatggcgaaagttgcgttaggtgcggagaaaatgccaagca ttaatgtgtctaaacaccgtatgaacg ttcaattcgagtctattgaagaatctgttgcgatgtctgcaatgtatgcggcaaaccaca tgagaggcgtagcggcgattatcacattaa caagtagcggtcgtactgctcgtttaatgtctagactccataggccgctttcctggcttt gcttccagatgtatgctctcctccggagagtac cgtgactttattttcggcacaaatacaggggtcgatggataaatacggcgatagtttcct gacggatgatccgtatgtaccggcggaag acaagctgcaaacctgtcagatggagattgatttaatggcggatgtgctgagagcaccgc cccgtgaatccgcagaactgatccgct atgtgtttgcggatgattggccggaataaataaagccgggcttaatacagattaagcccg tatagggtattattactgaataccaaaca gcttacggaggacggaatgttacccattgagacaaccagactgccttctgattattaata tttttcactattaatcagaaggaataaccat gaattttacccggattgacctgaatacctggaatcgcagggaacactttgccctttatcg tcagcagattaaatgcggattcagcctgac caccaaactcgatattaccgctttgcgtaccgcactggcggagacaggttataagtttta tccgctgatgatttacctgatctcccgggct gttaatcagtttccggagttccggatggcactgaaagacaatgaacttatttactgggac cagtcagacccggtctttactgtctttcataa agaaaccgaaacattctctgcactgtcctgccgttattttccggatctcagtgagtttat ggcaggttataatgcggtaacggcagaatat cagcatgataccagattgtttccgcagggaaatttaccggagaatcacctgaatatatca tcattaccgtgggtgagttttgacgggattt aacctgaacatcaccggaaatgatgattattttgccccggtttttacgatggcaaagttt cagcaggaaggtgaccgcgtattattacctg tttctgtacaggttcatcatgcagtctgtgatggctttcatgcagcacggtttattaata cacttcagctgatgtgtgataacatactgaaata aattaattaattctgtatttaagccaccgtatccggcaggaatggtggctttttttttat attttaaccgtaatctgtaatttcgtttcagactggttc aggatgagctcgcttggactcctgttgatagatccagtaatgacctcagaactccatctg gatttgttcagaacgctcggttgccgccgg gcgttttttattggtgagaatccaagcactagcggcgcgccggccggcccggtgtgaaat accgcacagatgcgtaaggagaaaat accgcatcaggcgctcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggc tgcggcgagcggtatcagctcactcaaag gcggtaatacggttatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaa ggccagcaaaaggccaggaacc gtaaaaaggccgcgttgctggcgtttttccataggctccgcccccctgacgagcatcaca aaaatcgacgctcaagtcagaggtggc gaaacccgacaggactataaagataccaggcgtttccccctggaagctccctcgtgcgct ctcctgttccgaccctgccgcttaccgg atacctgtccgcctttctcccttcgggaagcgtggcgctttctcatagctcacgctgtag gtatctcagttcggtgtaggtcgttcgctccaa gctgggctgtgtgcacgaaccccccgttcagcccgaccgctgcgccttatccggtaacta tcgtcttgagtccaacccggtaagacac gacttatcgccactggcagcagccactggtaacaggattagcagagcgaggtatgtaggc ggtgctacagagttcttgaagtggtgg cctaactacggctacactagaaggacagtatttggtatctgcgctctgctgaagccagtt accttcggaaaaagagttggtagctcttga tccggcaaacaaaccaccgctggtagcggtggtttttttgtttgcaagcagcagattacg cgcagaaaaaaaggatctcaagaagat cctttgatcttttctacggggtctgacgctcagtggaacgaaaactcacgttaagggatt ttggtcatgagattatcaaaaaggatcttcac ctagatccttttaaaggccggccgcggccgccatcggcattttcttttgcgtttttattt gttaactgttaattgtccttgttcaaggatgctgtcttt gacaacagatgttttcttgcctttgatgttcagcaggaagctcggcgcaaacgttgattg tttgtctgcgtagaatcctctgtttgtcatatag cttgtaatcacgacattgtttcctttcgcttgaggtacagcgaagtgtgagtaagtaaag gttacatcgttaggatcaagatccatttttaac acaaggccagttttgttcagcggcttgtatgggccagttaaagaattagaaacataacca agcatgtaaatatcgttagacgtaatgcc gtcaatcgtcatttttgatccgcgggagtcagtgaacaggtaccatttgccgttcatttt aaagacgttcgcgcgttcaatttcatctgttactg tgttagatgcaatcagcggtttcatcacttttttcagtgtgtaatcatcgtttagctcaa tcataccgagagcgccgtttgctaactcagccgt gcgttttttatcgctttgcagaagtttttgactttcttgacggaagaatgatgtgctttt gccatagtatgctttgttaaataaagattcttcgcctt ggtagccatcttcagttccagtgtttgcttcaaatactaagtatttgtggcctttatctt ctacgtagtgaggatctctcagcgtatggttgtcgc ctgagctgtagttgccttcatcgatgaactgctgtacattttgatacgtttttccgtcac cgtcaaagattgatttataatcctctacaccgttga tgttcaaagagctgtctgatgctgatacgttaacttgtgcagttgtcagtgtttgtttgc cgtaatgtttaccggagaaatcagtgtagaataa acggatttttccgtcagatgtaaatgtggctgaacctgaccattcttgtgtttggtcttt taggatagaatcatttgcatcgaatttgtcgctgtct ttaaagacgcggccagcgtttttccagctgtcaatagaagtttcgccgactttttgatag aacatgtaaatcgatgtgtcatccgcattttta ggatctccggctaatgcaaagacgatgtggtagccgtgatagtttgcgacagtgccgtca gcgttttgtaatggccagctgtcccaaac gtccaggccttttgcagaagagatatttttaattgtggacgaatcaaattcagaaacttg atatttttcatttttttgctgttcagggatttgcag catatcatggcgtgtaatatgggaaatgccgtatgtttccttatatggcttttggttcgt ttctttcgcaaacgcttgagttgcgcctcctgccag cagtgcggtagtaaaggttaatactgttgcttgttttgcaaactttttgatgttcatcgt tcatgtctccttttttatgtactgtgttagcggtctgctt cttccagccctcctgtttgaagatggcaagttagttacgcacaataaaaaaagacctaaa atatgtaaggggtgacgccaaagtatac actttgccctttacacattttaggtcttgcctgctttatcagtaacaaacccgcgcgatt tacttttcgacctcattctattagactctcgtttggat tgcaactggtctattttcctcttttgtttgatagaaaatcataaaaggatttgcagacta cgggcctaaagaactaaaaaatctatctgtttctt ttcattctctgtattttttatagtttctgttgcatgggcataaagttgcctttttaatca caattcagaaaatatcataatatctcatttcactaaata atagtgaacggcaggtatatgtgatgggttaaaaaggatcggcggccgctcgatttaaat c SEQ ID NO: 21 (complete nucleotide sequence of plasmid pSacB_wcaJ ^* )

tcgagtaagccgattcagctgatccgccacatggggaaaaagcctaatctgcggaat atgaaaccgataccagtccagtaaagttg acaaatcgacatcatattgctcaaccaagtattgaaaagcgttttcaccgcgatgataca attcgaccagccggttaaataacgtttcac tccgttccggtgccaaacgagacgcaatatgcttataggcggaatacagaaaatcgattt ccgcataaagcgtatcgtccaaatctaa aaccaacgctttatttttcataatgatgagccagtacttccgcgtcataccgcaacatta ataaatccgcttcccagtcttcgaacgcagg aatcggctgattaaacaaatattcctgaatcaaccaacggggataattggctcccgccag ataactcaacggataaccgccgccga acctagggttaatttcaataccaagaatttcagcggtggattccttataaaatacttgga ttgttaagcaaccgcgcgcccccggtaaac gggacaatttttccgataattgcgtcacgatggcattttttctggtcacacctttgttaa tttcccccgctctgacaaaaattctctttctcggta ccgcacttttcagttcggaatttttatcaaaataacaatccacggtatattcgtcgtatt ccgccggcgaaatatattgcataaacattaattc gggattttccaattgctccggtgaaatatcttccggtttctccgccacaaaaattccttt acttaaactaccgttgtaaggcttcacaaaaac aggatattcaaattgacctttttcaaactgcttcggtaccgcaatattatgttcaataaa cagttgattggttaatcgtttgtcgcgacattttct gacaaactctgtatcactaacggaaataaaaatacctttttctttaaaccgttgcagatg ttcgcttaaaataagcaattccgtatcaatag tcggaataatcaatttcacgttattttcttcacagattttaagtaaggtcggaatatact ccgcatcagtgacccggggtacaggaaaatgt ccgtcggccacataacaagccggcgccaactcgggatttaaatctacggttaacactttt ccgtcacttactaactgcgataattccttttt aaacgcctgaacgagagaaacacgttgtccggccgatgtaacaagaatattcatgatttt ttattcccttcaaatttaggcatggtggcat catctgccgcattaatatcgtcttttgcgatcactttttggatggtctttgcgataattt tcaaatccagccacaaggattgatgttcaacatac caggcatccaattcaaatttctgctcccaactgatggcattgcgaccgtttacctgtgca taaccggtaattccgggtttcacttcatggcg cttagcctgtctttcgttatacagcggcaaatattccatcagtagaggacgcggccccac cagactcatatcaccttttaatacattccaa agttccggcaactcgtccagactggtagcgcgcaacattttgccgaaaggtgttaagcgc tccgcatccggcaaaatattaccgttttc atctgcgccgtctttcattgttctgaacttaatcatctcaaagggtttaccatgcaatcc ggggcgggtttgtttaaataacaccggtgatcc caaattttgttttaccttgataagccacaaacaaatataagggcgaaaacaaaatcaatg ctatcaatgcgacaacaatatcgaaaag gcgttttatcatgaaaatctcctacgaccgaccaatttggggctgacaaaagtgccgttt ttcaccagaaccgtataaactaaaaccag gaaaagcggataccagactaacggcagtcttaatatggaagacggcacccaaacgatcca acaaaaattaataaaaataaataa aataaatatacgttctttccacgccaacaattgggtattcatcacatagataattgaatt taataaaaaatatataaatgccaaaaatgca aaaatgccaaatgccaaataaagttctataaagaagctatgcggattagtgtaacccaaa gggaaacttaactttatttgatcgaaata ctgaatgtagtcccgcggtccataacccaaccataaaattttaaaattatctaaaaatgt cgtataaatttccgtccggtaacctacggac ttatcatcgcccatagaaaatattaccaatgaaaaacgttcaatcggacgctccagccaa tcaattttggcgagcagaataaacacttc ctgtaaccaagaaagattaaatataaataatgcgatcacgcaggcgaaaaacagatatac cgccttaaaataggtagatgcgtttaa aaacaagatcagcatcaacataatcaaatagctcagtaataccgaacgggaggcactgat cacaatagctaaccccataataaaa ataagagcatagccgattaacttaattttccagttgttttctctgatgatgtaaaaaaat cccaccgccaccgcaagagaaatcataatta cggactggtcattggtattaaagaaaaaacctttaaacgccttatcagttacggttaatt cttcattacccgaaaccaactggaacccca ataaagcctcaataaaaaagcccgccagcacaattaatgatattcccaacaaaaggtgcc taatccctgcttctccatcaccccggtt aaacgtcaaaaaagaataatgaaataaaaacatcacaattccgaagaaaaacaaatcaac taatttttctgtagaaaacgcatttaa taccgataaaaagccgaagaaaaacaacacgtacaccggaaactgtaatttaaaaaaatc agtttccatatcccttaaaaaagggg ttattaccgctaagaaaaagaacaaaaaacacaacgcactatctaacctcggcactccta tttgtgtcgatagtgcgggagaaagtat caccagtcccaacgcaaagagtaatagcaacttaaaaatgctgataacattaatattcat atcaaataatatttttgattaatttctcaattt ctttataagaacgctcgcgcagaaacttctcttttgccagcgataaattcacttgcgaca ttttgtctaaaaccgttctgtcttcggccaattt attcaacgtctcagccaactcccgataatctcccgccgtatattgaattccaccgccttt cgccagtagtttttccacttcaggatgtttctga cagcttacaatcggtaatgcgcaacagatataatcggatctagactccataggccgcttt cctggctttgcttccagatgtatgctctcctc cggagagtaccgtgactttattttcggcacaaatacaggggtcgatggataaatacggcg atagtttcctgacggatgatccgtatgtac cggcggaagacaagctgcaaacctgtcagatggagattgatttaatggcggatgtgctga gagcaccgccccgtgaatccgcaga actgatccgctatgtgtttgcggatgattggccggaataaataaagccgggcttaataca gattaagcccgtatagggtattattactga ataccaaacagcttacggaggacggaatgttacccattgagacaaccagactgccttctg attattaatatttttcactattaatcagaag gaataaccatgaattttacccggattgacctgaatacctggaatcgcagggaacactttg ccctttatcgtcagcagattaaatgcggat tcagcctgaccaccaaactcgatattaccgctttgcgtaccgcactggcggagacaggtt ataagttttatccgctgatgatttacctgat ctcccgggctgttaatcagtttccggagttccggatggcactgaaagacaatgaacttat ttactgggaccagtcagacccggtctttact gtctttcataaagaaaccgaaacattctctgcactgtcctgccgttattttccggatctc agtgagtttatggcaggttataatgcggtaacg gcagaatatcagcatgataccagattgtttccgcagggaaatttaccggagaatcacctg aatatatcatcattaccgtgggtgagttttg acgggatttaacctgaacatcaccggaaatgatgattattttgccccggtttttacgatg gcaaagtttcagcaggaaggtgaccgcgta ttattacctgtttctgtacaggttcatcatgcagtctgtgatggctttcatgcagcacgg tttattaatacacttcagctgatgtgtgataacata ctgaaataaattaattaattctgtatttaagccaccgtatccggcaggaatggtggcttt ttttttatattttaaccgtaatctgtaatttcgtttca gactggttcaggatgagctcgcttggactcctgttgatagatccagtaatgacctcagaa ctccatctggatttgttcagaacgctcggttg ccgccgggcgttttttattggtgagaatccaagcactagcggcgcgccggccggcccggt gtgaaataccgcacagatgcgtaagg agaaaataccgcatcaggcgctcttccgcttcctcgctcactgactcgctgcgctcggtc gttcggctgcggcgagcggtatcagctca ctcaaaggcggtaatacggttatccacagaatcaggggataacgcaggaaagaacatgtg agcaaaaggccagcaaaaggcca ggaaccgtaaaaaggccgcgttgctggcgtttttccataggctccgcccccctgacgagc atcacaaaaatcgacgctcaagtcaga ggtggcgaaacccgacaggactataaagataccaggcgtttccccctggaagctccctcg tgcgctctcctgttccgaccctgccgctt accggatacctgtccgcctttctcccttcgggaagcgtggcgctttctcatagctcacgc tgtaggtatctcagttcggtgtaggtcgttcgc tccaagctgggctgtgtgcacgaaccccccgttcagcccgaccgctgcgccttatccggt aactatcgtcttgagtccaacccggtaag acacgacttatcgccactggcagcagccactggtaacaggattagcagagcgaggtatgt aggcggtgctacagagttcttgaagtg gtggcctaactacggctacactagaaggacagtatttggtatctgcgctctgctgaagcc agttaccttcggaaaaagagttggtagct cttgatccggcaaacaaaccaccgctggtagcggtggtttttttgtttgcaagcagcaga ttacgcgcagaaaaaaaggatctcaaga agatcctttgatcttttctacggggtctgacgctcagtggaacgaaaactcacgttaagg gattttggtcatgagattatcaaaaaggatct tcacctagatccttttaaaggccggccgcggccgccatcggcattttcttttgcgttttt atttgttaactgttaattgtccttgttcaaggatgct gtctttgacaacagatgttttcttgcctttgatgttcagcaggaagctcggcgcaaacgt tgattgtttgtctgcgtagaatcctctgtttgtcat atagcttgtaatcacgacattgtttcctttcgcttgaggtacagcgaagtgtgagtaagt aaaggttacatcgttaggatcaagatccatttt taacacaaggccagttttgttcagcggcttgtatgggccagttaaagaattagaaacata accaagcatgtaaatatcgttagacgtaa tgccgtcaatcgtcatttttgatccgcgggagtcagtgaacaggtaccatttgccgttca ttttaaagacgttcgcgcgttcaatttcatctgtt actgtgttagatgcaatcagcggtttcatcacttttttcagtgtgtaatcatcgtttagc tcaatcataccgagagcgccgtttgctaactcag ccgtgcgttttttatcgctttgcagaagtttttgactttcttgacggaagaatgatgtgc ttttgccatagtatgctttgttaaataaagattcttcg ccttggtagccatcttcagttccagtgtttgcttcaaatactaagtatttgtggccttta tcttctacgtagtgaggatctctcagcgtatggttgt cgcctgagctgtagttgccttcatcgatgaactgctgtacattttgatacgtttttccgt caccgtcaaagattgatttataatcctctacaccg ttgatgttcaaagagctgtctgatgctgatacgttaacttgtgcagttgtcagtgtttgt ttgccgtaatgtttaccggagaaatcagtgtaga ataaacggatttttccgtcagatgtaaatgtggctgaacctgaccattcttgtgtttggt cttttaggatagaatcatttgcatcgaatttgtcgc tgtctttaaagacgcggccagcgtttttccagctgtcaatagaagtttcgccgacttttt gatagaacatgtaaatcgatgtgtcatccgcat ttttaggatctccggctaatgcaaagacgatgtggtagccgtgatagtttgcgacagtgc cgtcagcgttttgtaatggccagctgtccca aacgtccaggccttttgcagaagagatatttttaattgtggacgaatcaaattcagaaac ttgatatttttcatttttttgctgttcagggatttg cagcatatcatggcgtgtaatatgggaaatgccgtatgtttccttatatggcttttggtt cgtttctttcgcaaacgcttgagttgcgcctcctgc cagcagtgcggtagtaaaggttaatactgttgcttgttttgcaaactttttgatgttcat cgttcatgtctccttttttatgtactgtgttagcggtct gcttcttccagccctcctgtttgaagatggcaagttagttacgcacaataaaaaaagacc taaaatatgtaaggggtgacgccaaagt atacactttgccctttacacattttaggtcttgcctgctttatcagtaacaaacccgcgc gatttacttttcgacctcattctattagactctcgttt ggattgcaactggtctattttcctcttttgtttgatagaaaatcataaaaggatttgcag actacgggcctaaagaactaaaaaatctatct gtttcttttcattctctgtattttttatagtttctgttgcatgggcataaagttgccttt ttaatcacaattcagaaaatatcataatatctcatttcact aaataatagtgaacggcaggtatatgtgatgggttaaaaaggatcggcggccgctcgatt taaatc SEQ ID NO: 22 (complete nucleotide sequence of plasmid pSacB_delta_pfsA)

tcgagtcgcaatgtcctattttagacatagcctccgtaagcgcatgggctaaattca taccgccgctgcgatcccgttgcaaaagatgat atgccatacgctgtgcggatttcggcccgacaccgggcaaacagcgtaaactttcgatta aattttctaataaaggactggtttgcataa gactctaaaaataacaaaaaacaaaccgcacttttaaaagtgcggtcttatttcataaaa ttttacttaaaacggcattttaaaacccgg aggaatcggcataccagcggtaactgacgccattttctctttttgtaactcatccgcgcg gcgagcggcatcattaaatgcggcggcga tgagatcttccaacatatccttatcgtcttccattaatgaaggatcaatttccacgcgac ggcaattatgcgcaccgttaattgttactttaac taaccccgcaccggactcaccggttacttcaagttgggcaatttcttcctgcattttttg catacgctcttgcatttgctgagcttgtttcattaa attgcctaagccaccttttccaaacataattcttcttccatttttgagcgtataaaatat acgaataaattaaataaaaagtccgctctaaac aaagcgaactttctaacaattataatgagactaatcagcttttatttttttagtgataaa accactgaatcgccggcaacaacctggccta cttttttatccaacgcactaatttcatccatatttgaaattactaccggagtaagaatag atttcgctttttgttctaaaagtggtaaatcaaact caataatagtatcaccacgtttcacagactgaccctcttgtgcaacacgggtaaaacctt cacctttaagttcaacggtatcaataccga agtgaacaaataattcaataccttcttttgattccattgaaaatgcatgatttgtttcaa aaatcttgccaatcacgccgtccaccggtgcaa caattttgtcaccgttcggacgaatcgcaataccgtcgccaacgattttttcagaaaaaa ccacatccggtacatcttcaatattaacaat ttcacctgaaagcggcgcataaatgtccacttctacggttttactattttttgaaccaaa taatttatcaaataagcccattttttaatctcctga atcgacaattttccgtattctacatgaaaaacatgaatttgtatctaatttaatgttttt tcagctaaaaaatcagcaactaatttttcaatttcg gcagcagtcggtaattgcagggctttatccgctaatgcttttgcttcggcaaaattaaca ctacgaaccaattttttaatacgaggaacgg aaatagcgctcatgctgaattcgtctaatcccatacctaataataaaatagtggcttttt catcaccggctaactcaccgcacataccagt ccatttgccttcggtatgagaggcgtcacgccgtacggccttcataaaaacgagctactt cagtttcaacttgatcttcagcaattttttgca tatcaagtacaattttttcctctttcagaactaacgctttaccaaaaacgatacctggtg aggccgggattcctgaaatcatgtgtaaccttc cgataataatttaattaaaaaaatctaactatgataaacgacatagccataaaactcttt tattaacagtgataaatcaataagaaagtttt atggccagacaaattattctaatgtaggaattaatgcaactaaatggtcaacagcatttt gctcatcttcgccttcagctgaaattgtaatta cagttccttgagttaagcctaaagtttgtaatttgaataaacttttcgcacttgcacttt taccggcagaagtcactgttacatcagatgcaa acgcttttgcttcttttacaaattgtgcagccggacgagtgtgtaagccgttaggagctg taatttcaacatcttttgaatacataattttacct ctaatagtaatgttttttgttttaatgtggagcaaacaggtaaacggttaacttttgacc tgcctactaaaatttaattattcataaaccacag cggacactctaaaccattttgtctgatagttcaaaataaatcttatttagtatcaagatt attcctaattaattcaagttaaatcctataaaaac ttgagctagttcatctttttgtcaaccgatagattaatttttaataaaaatgtaacaaat tagtaataaaaaataaccgaattaccttatatcct gctccataaaatggcgttgcgatttattttcttcccggcttgaaatcaagcgatggtaat tatcaaatctgacggggtggattttcccgagct ccacagcttcccgtaaggcgcagcccggatcatcaatatgtttgcagtctctgaatttgc aggtccctaagaaatattggaattcccgat aaccgttggtgatttgtgcaggttccaaatgccataaaccgaactctcgaatgcccggcg aatcaatcagatttccgccctgaggtaaa tgatataaacgggaagacgtggtggtatgctgtcccaatcccgaagtttcgctgatttca ccggtttgcgcattaacttccggtaaaatat agttgattaaactggacttccctaccccggattgcccgacgaaaatcgacgtaccatccg ctaaaagtgcggtcagtttttccatatttttt ccactaatcgccgaaatcattaatgtttcatagccgatttttcggtagatttccagttgt tcttccgcttcccgccactgttcgtccgttaataaa tcaaccttattcaacaagataacggcaggaatattagcgttttcacaaataaccaaataa cgatcaataatattcagggataacgccg gtagcaccgacgaaacaataataatgcgatcgatattcgatgccattctagactccatag gccgctttcctggctttgcttccagatgtat gctctcctccggagagtaccgtgactttattttcggcacaaatacaggggtcgatggata aatacggcgatagtttcctgacggatgatc cgtatgtaccggcggaagacaagctgcaaacctgtcagatggagattgatttaatggcgg atgtgctgagagcaccgccccgtgaat ccgcagaactgatccgctatgtgtttgcggatgattggccggaataaataaagccgggct taatacagattaagcccgtatagggtatt attactgaataccaaacagcttacggaggacggaatgttacccattgagacaaccagact gccttctgattattaatatttttcactattaa tcagaaggaataaccatgaattttacccggattgacctgaatacctggaatcgcagggaa cactttgccctttatcgtcagcagattaa atgcggattcagcctgaccaccaaactcgatattaccgctttgcgtaccgcactggcgga gacaggttataagttttatccgctgatgatt tacctgatctcccgggctgttaatcagtttccggagttccggatggcactgaaagacaat gaacttatttactgggaccagtcagacccg gtctttactgtctttcataaagaaaccgaaacattctctgcactgtcctgccgttatttt ccggatctcagtgagtttatggcaggttataatgc ggtaacggcagaatatcagcatgataccagattgtttccgcagggaaatttaccggagaa tcacctgaatatatcatcattaccgtggg tgagttttgacgggatttaacctgaacatcaccggaaatgatgattattttgccccggtt tttacgatggcaaagtttcagcaggaaggtg accgcgtattattacctgtttctgtacaggttcatcatgcagtctgtgatggctttcatg cagcacggtttattaatacacttcagctgatgtgt gataacatactgaaataaattaattaattctgtatttaagccaccgtatccggcaggaat ggtggctttttttttatattttaaccgtaatctgta atttcgtttcagactggttcaggatgagctcgcttggactcctgttgatagatccagtaa tgacctcagaactccatctggatttgttcagaa cgctcggttgccgccgggcgttttttattggtgagaatccaagcactagcggcgcgccgg ccggcccggtgtgaaataccgcacagat gcgtaaggagaaaataccgcatcaggcgctcttccgcttcctcgctcactgactcgctgc gctcggtcgttcggctgcggcgagcggt atcagctcactcaaaggcggtaatacggttatccacagaatcaggggataacgcaggaaa gaacatgtgagcaaaaggccagca aaaggccaggaaccgtaaaaaggccgcgttgctggcgtttttccataggctccgcccccc tgacgagcatcacaaaaatcgacgct caagtcagaggtggcgaaacccgacaggactataaagataccaggcgtttccccctggaa gctccctcgtgcgctctcctgttccga ccctgccgcttaccggatacctgtccgcctttctcccttcgggaagcgtggcgctttctc atagctcacgctgtaggtatctcagttcggtgt aggtcgttcgctccaagctgggctgtgtgcacgaaccccccgttcagcccgaccgctgcg ccttatccggtaactatcgtcttgagtcca acccggtaagacacgacttatcgccactggcagcagccactggtaacaggattagcagag cgaggtatgtaggcggtgctacaga gttcttgaagtggtggcctaactacggctacactagaaggacagtatttggtatctgcgc tctgctgaagccagttaccttcggaaaaag agttggtagctcttgatccggcaaacaaaccaccgctggtagcggtggtttttttgtttg caagcagcagattacgcgcagaaaaaaag gatctcaagaagatcctttgatcttttctacggggtctgacgctcagtggaacgaaaact cacgttaagggattttggtcatgagattatca aaaaggatcttcacctagatccttttaaaggccggccgcggccgccatcggcattttctt ttgcgtttttatttgttaactgttaattgtccttgtt caaggatgctgtctttgacaacagatgttttcttgcctttgatgttcagcaggaagctcg gcgcaaacgttgattgtttgtctgcgtagaatc ctctgtttgtcatatagcttgtaatcacgacattgtttcctttcgcttgaggtacagcga agtgtgagtaagtaaaggttacatcgttaggatc aagatccatttttaacacaaggccagttttgttcagcggcttgtatgggccagttaaaga attagaaacataaccaagcatgtaaatatc gttagacgtaatgccgtcaatcgtcatttttgatccgcgggagtcagtgaacaggtacca tttgccgttcattttaaagacgttcgcgcgttc aatttcatctgttactgtgttagatgcaatcagcggtttcatcacttttttcagtgtgta atcatcgtttagctcaatcataccgagagcgccgtt tgctaactcagccgtgcgttttttatcgctttgcagaagtttttgactttcttgacggaa gaatgatgtgcttttgccatagtatgctttgttaaata aagattcttcgccttggtagccatcttcagttccagtgtttgcttcaaatactaagtatt tgtggcctttatcttctacgtagtgaggatctctcag cgtatggttgtcgcctgagctgtagttgccttcatcgatgaactgctgtacattttgata cgtttttccgtcaccgtcaaagattgatttataatc ctctacaccgttgatgttcaaagagctgtctgatgctgatacgttaacttgtgcagttgt cagtgtttgtttgccgtaatgtttaccggagaaat cagtgtagaataaacggatttttccgtcagatgtaaatgtggctgaacctgaccattctt gtgtttggtcttttaggatagaatcatttgcatc gaatttgtcgctgtctttaaagacgcggccagcgtttttccagctgtcaatagaagtttc gccgactttttgatagaacatgtaaatcgatgt gtcatccgcatttttaggatctccggctaatgcaaagacgatgtggtagccgtgatagtt tgcgacagtgccgtcagcgttttgtaatggc cagctgtcccaaacgtccaggccttttgcagaagagatatttttaattgtggacgaatca aattcagaaacttgatatttttcatttttttgctgt tcagggatttgcagcatatcatggcgtgtaatatgggaaatgccgtatgtttccttatat ggcttttggttcgtttctttcgcaaacgcttgagtt gcgcctcctgccagcagtgcggtagtaaaggttaatactgttgcttgttttgcaaacttt ttgatgttcatcgttcatgtctccttttttatgtactg tgttagcggtctgcttcttccagccctcctgtttgaagatggcaagttagttacgcacaa taaaaaaagacctaaaatatgtaaggggtg acgccaaagtatacactttgccctttacacattttaggtcttgcctgctttatcagtaac aaacccgcgcgatttacttttcgacctcattctatt agactctcgtttggattgcaactggtctattttcctcttttgtttgatagaaaatcataa aaggatttgcagactacgggcctaaagaactaa aaaatctatctgtttcttttcattctctgtattttttatagtttctgttgcatgggcata aagttgcctttttaatcacaattcagaaaatatcataata tctcatttcactaaataatagtgaacggcaggtatatgtgatgggttaaaaaggatcggc ggccgctcgatttaaatc

SEQ ID NO: 23 (complete nucleotide sequence of plasmid pSacB_delta_pfsH)

tcgagccgatactgaagaagtccacttcttttgctaagaattttgcatttactgcag ctgacggcgtttcacacattacaccgatttgaatatt ttcatcaaaggctttaccttcggtgcgtaattcttgttttaaagtttcgataacggattt caattcgcgaatttcttcaacggaaataatcatcg ggaacattaccgctaatttaccgaatgcggaagcacgtaataccgcacgcaattgagcat ttaagatttcgcgacgatccaatgcgat acgaaccgcacgccagcctaagaacggattcatttcttttggcagattcatataaggtaa ttctttatctccaccaatatccatggtacgta ataccacctggcgaccgttcatcgcttctaccacttctttataagcgataaattgttctt cttctgaaggcagttggtcacgatccatgaaca ggaactcggtacggtataaaccgacaccttccgcaccgttacgatccgcaccctcacagt cacgaatcgtaccgatattcgccacca cttcaacacggtgaccgtccaatgttactgccggtaaatcttttaatttagctaattccg ctttttcttccgctaattttgcttgttgggcttttaag ccgtcaatcacgtcttgagccggattcacataaacagcgttattgattgcatcaagtact aaataatcaccgctgttaatcattgcggttgc attatttgtacctacaattgccggtaattccagcgaacgggccataatagaggtatgtga agtacgaccaccgatatcagtaataaaac ctaatactttgtctaaattcaattgtgcggtttctgatggcgttaagtcataagcaacca agattgactcttcattgatttcgcccaaatccac aattttcatgcctaagatatttttaattaaacggttaccgatatcgcgaatatcgccggc acgttcttttaagtactcatcatcaatatccgca agcatagcaacttgttgatcaatgattttacttgccgcaacgcccgcatttactttgttt gaacgcaaataatcaatgatttcttcttccaactc ttcatcttcaagaatcattaaatgaccttcgaagatagccgctttttcttcaccgagagt tttctctgcacgatctctaatggcgcttaattgttc cactgccgccgtacggccttcataaaaacgagctacttcagtttcaacttgatcttcagc aattttttgcatatcaagtacaattttttcctcttt cagaactaacgctttaccaaaaacgatacctggtgaggccgggattcctgaaatcatgtg taaccttccgataataatttaattaaaaa aatctaactatgataaacgacatagccataaaactcttttattaacagtgataaatcaat aagaaagttttatggccagacaaattattct aatgtaggaattaatgcaactaaatggtcaacagcattttgctcatcttcgccttcaacc tctaatagtaatgttttttgttttaatgtggagca aacaggtaaacggttaacttttgacctgcctactaaaatttaattattcataaaccacag cggacactctaaaccattttgtctgatagttc aaaataaatcttatttagtatcaagattattcctaattaattcaagttaaatcctataaa aacttgagctagttcatctttttgtcaaccgatag attaatttttaataaaaatgtaacaaattagtaataaaaaataaccgaattaccttatat cctgctccataaaatggcgttgcgatttattttct tcccggcttgaaatcaagcgatggtaattatcaaatctgacggggtggattttcccgagc tccacagcttcccgtaaggcgcagcccg gatcatcaatatgtttgcagtctctgaatttgcaggtccctaagaaatattggaattccc gataaccgttggtgatttgtgcaggttccaaat gccataaaccgaactctcgaatgcccggcgaatcaatcagatttccgccctgaggtaaat gatataaacgggaagacgtggtggtat gctgtcccaatcccgaagtttcgctgatttcaccggtttgcgcattaacttccggtaaaa tatagttgattaaactggacttccctaccccgg attgcccgacgaaaatcgacgtaccatccgctaaaagtgcggtcagtttttccatatttt ttccactaatcgccgaaatcattaatgtttcat agccgatttttcggtagatttccagttgttcttccgcttcccgccactgttcgtccgtta ataaatcaaccttattcaacaagataacggcag gaatattagcgttttcacaaataaccaaataacgatcaataatattcagggataacgccg gtagcaccgacgaaacaataataatgc gatcgatattcgatgccatgactttcagtccgtcataataatccgggcgggcaatttcat tttcacgcggtttaatcgcctcaatgaccccg ctaataccctgtagtttttcatgccctcggcgccacactacgtgatctcccaccaccaca ttggctaatgtgcgacgtaaattacaacgg aaaatctcgccttgactattctccacatccgcatgcatagaataacgagtgacgacaacg ccgtcttgcgtatcgccaagcatttcttcct gccaatcaatctctttttttactcttcggtgatgacgatccaatgcttttacattatttg aatgaattcgacgtttttgattttgagttaatttacgctt agtcaaacagaagtccttaaagtgcggtagattttcgtataatattacgggtcaacaaat cagttaacgtataaatgcttataggatactc caaattatgcaattagataaccaaaatctaatctggatcgacttagaaatgaccgggtta gaccctgaaaacgagcgcattattgaaat cgccaccatctagactccataggccgctttcctggctttgcttccagatgtatgctctcc tccggagagtaccgtgactttattttcggcaca aatacaggggtcgatggataaatacggcgatagtttcctgacggatgatccgtatgtacc ggcggaagacaagctgcaaacctgtca gatggagattgatttaatggcggatgtgctgagagcaccgccccgtgaatccgcagaact gatccgctatgtgtttgcggatgattggc cggaataaataaagccgggcttaatacagattaagcccgtatagggtattattactgaat accaaacagcttacggaggacggaatg ttacccattgagacaaccagactgccttctgattattaatatttttcactattaatcaga aggaataaccatgaattttacccggattgacct gaatacctggaatcgcagggaacactttgccctttatcgtcagcagattaaatgcggatt cagcctgaccaccaaactcgatattaccg ctttgcgtaccgcactggcggagacaggttataagttttatccgctgatgatttacctga tctcccgggctgttaatcagtttccggagttcc ggatggcactgaaagacaatgaacttatttactgggaccagtcagacccggtctttactg tctttcataaagaaaccgaaacattctctg cactgtcctgccgttattttccggatctcagtgagtttatggcaggttataatgcggtaa cggcagaatatcagcatgataccagattgtttc cgcagggaaatttaccggagaatcacctgaatatatcatcattaccgtgggtgagttttg acgggatttaacctgaacatcaccggaaa tgatgattattttgccccggtttttacgatggcaaagtttcagcaggaaggtgaccgcgt attattacctgtttctgtacaggttcatcatgca gtctgtgatggctttcatgcagcacggtttattaatacacttcagctgatgtgtgataac atactgaaataaattaattaattctgtatttaagc caccgtatccggcaggaatggtggctttttttttatattttaaccgtaatctgtaatttc gtttcagactggttcaggatgagctcgcttggactc ctgttgatagatccagtaatgacctcagaactccatctggatttgttcagaacgctcggt tgccgccgggcgttttttattggtgagaatcca agcactagcggcgcgccggccggcccggtgtgaaataccgcacagatgcgtaaggagaaa ataccgcatcaggcgctcttccgct tcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagcggtatcagctcac tcaaaggcggtaatacggttatccacaga atcaggggataacgcaggaaagaacatgtgagcaaaaggccagcaaaaggccaggaaccg taaaaaggccgcgttgctggcg tttttccataggctccgcccccctgacgagcatcacaaaaatcgacgctcaagtcagagg tggcgaaacccgacaggactataaag ataccaggcgtttccccctggaagctccctcgtgcgctctcctgttccgaccctgccgct taccggatacctgtccgcctttctcccttcgg gaagcgtggcgctttctcatagctcacgctgtaggtatctcagttcggtgtaggtcgttc gctccaagctgggctgtgtgcacgaaccccc cgttcagcccgaccgctgcgccttatccggtaactatcgtcttgagtccaacccggtaag acacgacttatcgccactggcagcagcc actggtaacaggattagcagagcgaggtatgtaggcggtgctacagagttcttgaagtgg tggcctaactacggctacactagaagg acagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaagagttggtagc tcttgatccggcaaacaaaccaccgctggt agcggtggtttttttgtttgcaagcagcagattacgcgcagaaaaaaaggatctcaagaa gatcctttgatcttttctacggggtctgacg ctcagtggaacgaaaactcacgttaagggattttggtcatgagattatcaaaaaggatct tcacctagatccttttaaaggccggccgc ggccgccatcggcattttcttttgcgtttttatttgttaactgttaattgtccttgttca aggatgctgtctttgacaacagatgttttcttgcctttgat gttcagcaggaagctcggcgcaaacgttgattgtttgtctgcgtagaatcctctgtttgt catatagcttgtaatcacgacattgtttcctttcg cttgaggtacagcgaagtgtgagtaagtaaaggttacatcgttaggatcaagatccattt ttaacacaaggccagttttgttcagcggctt gtatgggccagttaaagaattagaaacataaccaagcatgtaaatatcgttagacgtaat gccgtcaatcgtcatttttgatccgcggga gtcagtgaacaggtaccatttgccgttcattttaaagacgttcgcgcgttcaatttcatc tgttactgtgttagatgcaatcagcggtttcatc acttttttcagtgtgtaatcatcgtttagctcaatcataccgagagcgccgtttgctaac tcagccgtgcgttttttatcgctttgcagaagttttt gactttcttgacggaagaatgatgtgcttttgccatagtatgctttgttaaataaagatt cttcgccttggtagccatcttcagttccagtgtttg cttcaaatactaagtatttgtggcctttatcttctacgtagtgaggatctctcagcgtat ggttgtcgcctgagctgtagttgccttcatcgatg aactgctgtacattttgatacgtttttccgtcaccgtcaaagattgatttataatcctct acaccgttgatgttcaaagagctgtctgatgctga tacgttaacttgtgcagttgtcagtgtttgtttgccgtaatgtttaccggagaaatcagt gtagaataaacggatttttccgtcagatgtaaat gtggctgaacctgaccattcttgtgtttggtcttttaggatagaatcatttgcatcgaat ttgtcgctgtctttaaagacgcggccagcgtttttc cagctgtcaatagaagtttcgccgactttttgatagaacatgtaaatcgatgtgtcatcc gcatttttaggatctccggctaatgcaaagac gatgtggtagccgtgatagtttgcgacagtgccgtcagcgttttgtaatggccagctgtc ccaaacgtccaggccttttgcagaagagat atttttaattgtggacgaatcaaattcagaaacttgatatttttcatttttttgctgttc agggatttgcagcatatcatggcgtgtaatatgggaa atgccgtatgtttccttatatggcttttggttcgtttctttcgcaaacgcttgagttgcg cctcctgccagcagtgcggtagtaaaggttaatact gttgcttgttttgcaaactttttgatgttcatcgttcatgtctccttttttatgtactgt gttagcggtctgcttcttccagccctcctgtttgaagatgg caagttagttacgcacaataaaaaaagacctaaaatatgtaaggggtgacgccaaagtat acactttgccctttacacattttaggtctt gcctgctttatcagtaacaaacccgcgcgatttacttttcgacctcattctattagactc tcgtttggattgcaactggtctattttcctcttttgttt gatagaaaatcataaaaggatttgcagactacgggcctaaagaactaaaaaatctatctg tttcttttcattctctgtattttttatagtttctgt tgcatgggcataaagttgcctttttaatcacaattcagaaaatatcataatatctcattt cactaaataatagtgaacggcaggtatatgtg atgggttaaaaaggatcggcggccgctcgatttaaatc Print Out (Original in Electronic Form)

(This sheet is not part of and does not count as a sheet of the international application)

Indications are Made

FOR RECEIVING OFFICE USE ONLY

0-4 This form was received with the

international application: Yes

(yes or no)

0-4-1 Authorized officer

Kuiper-Cristina, Nathalie

FOR INTERNATIONAL BUREAU USE ONLY

0-5 This form was received by the

international Bureau on:

0-5-1 Authorized officer